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General Overview
The Department of Health Policy of Jefferson Medical College is committed to
conducting research and education programs, which contribute to the quality,
safety and cost-effectiveness of healthcare. The Department’s activities are
meant to inform decisions made by government policy makers, providers, payers
and other system stakeholders about how best to deliver and finance care in order
to improve the health of the public.
As reflected in this Departmental mission statement, the Department of Health Policy’s work is
central to the strategic plan of Thomas Jefferson University. Specifically, “Health Policy and
Population Health” is one of the five key strategic priorities as approved by the TJU Board of
Trustees. The Department looks forward to the challenge of participating in this strategic
priority and has organized its activities in this past academic year to meet that challenge.
Currently, the Department is proud to be celebrating its fourth anniversary, building on the
previous 14-year history of the Office of Health Policy and Clinical Outcomes. Our research and
education programs span a broad spectrum of policy issues including quality and safety
improvement in health care, development and implementation of evidence-based care protocols,
evaluation of healthcare delivery and financing programs, economic evaluation of healthcare
interventions (drugs, devices and programs), and development and implementation of best
practices for improving the health of the public. A table of organization for the Department is
included as an Appendix to this report.
The mission of the Department is implemented through three main strategies—education,
research and policy consulting services—which will be described in more detail later in this
report. In this introductory section, we will further delineate the connections between the
University’s top strategic priorities, the Departmental mission, and aspects of our work.
Healthcare Quality and Safety
One of the core components of the Department’s mission is improving the quality and safety of
medical care. The Department has made great progress on this front during the past academic
year. On the national level, the Department serves as the editorial home for the American
Journal of Medical Quality, one of the key peer-reviewed journals in our field. In late 2006,
AJMQ published a special supplement entitled “Hospital-Acquired Infections: Raising the
Anchoring Heuristic.” This supplement was the focus of a special briefing at the National Press
Club in Washington, DC on Monday, November 20, 2006. This press briefing attracted
tremendous national attention as the contributors to the supplement described their path-breaking
findings: that hospital-acquired infections are largely preventable, very expensive, and not
necessarily linked to the severity of illness of the patients upon admission. In short, the AJMQ
Supplement and the resulting national press attention clearly linked failed processes to an
increase in hospital-acquired infection.
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Through the publication of this special supplement and the national press conference, the
Department’s work was featured in more than a dozen national publications, including USA
Today, The Wall Street Journal, Pittsburgh Post-Gazette, Philadelphia Inquirer, AARP Bulletin,
and Modern Healthcare. Aspects of this important national work grew out of the Chair’s 10year tenure as the Chairperson of the Technical Advisory Group of the Pennsylvania Healthcare
Cost Containment Council (PHC4), original sponsors of the first statewide, tax supported HAI
Report. It is important to therefore link ongoing consulting work by the Chair, with research
dissemination through our journal, and changes in the public’s perception about important
quality related issues such as hospital-acquired infection. The Department contributes mightily
to the national debate about improving the quality and safety of healthcare through these
activities.
On a state policy level, we collaborated with a team from Baylor Health Care System in Dallas,
Texas, to conduct a demonstration project to implement rapid-cycle quality improvement
strategies at two rural community hospitals in Pennsylvania. The project, referred to as
“Accelerating Best Care in Pennsylvania”, was funded by the Commonwealth of Pennsylvania
through a grant to a non-profit organization called Improve Pennsylvania Community Care.
Members of the Jefferson-Baylor team conducted a site survey and interview with each of the
hospitals to identify areas for improvement. In January and February 2007, the team provided
specialized two-day education and training sessions. These were followed by telephonic and onsite coaching and support, to assist the hospital teams in developing their projects, refine their
objectives and measures, and troubleshoot the implementation of their self-identified quality
improvement initiatives. The results were shared in a special session in June 2007 at the State
Capitol Building in Harrisburg, Pennsylvania, and are now being prepared for publication.
We also are working diligently to support continuous quality improvement on the Jefferson
campus. As described further below, in the “Patient Care” section, through the Department’s
leadership and staffing for the Jefferson University Physicians (JUP) Clinical Care
Subcommittee, we are helping each JUP Department to implement performance measurement
and improvement initiatives, and to implement activities to support pay-for-performance
initiatives emanating from Independence Blue Cross, Medicare (CMS), and other payers. We
also are among the first academic group practices to implement the Physician Practice Patient
Safety Assessment (PPPSA), a national safety measurement tool developed by the Medical
Group Management Association, the Institute for Safe Medication Practices, and the Health
Research Education Trust. The tool is helping JUP practices to identify safety deficiencies in the
ambulatory setting and to design appropriate improvements.
Other quality and safety initiatives include developing a national migraine quality measurement
set, and collaborating with Quality Insights, the Pennsylvania Quality Improvement Organization
(QIO) on the development of provider-specialty-specific quality measures which could be
incorporated into public reporting and pay-for-performance initiatives. All of these activities
have put Jefferson at the forefront in the quality measurement and improvement movement. Our
collaborative work with the University HealthSystem Consortium has demonstrated that
Jefferson is now among the nation’s top academic health centers in terms of its programs to
improve ambulatory quality.
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Health Information Technology
Another good example of the Department’s role in the national debate to improve the quality and
safety of healthcare through consumer engagement is our ongoing consultative work with a
number of health information technology organizations in the private sector. For example, this
past year, the Department continued its affiliation with the global personal health record (PHR)
company InterComponentWare (ICW), headquartered just outside Frankfurt, Germany. For
more than two years, the Department has managed a national advisory board of experts drawn
from across the health information technology spectrum. Work of the ICW-DHP Advisory
Board was also featured in a special supplement to AJMQ. In addition, members of the National
Advisory Board then deployed back to their principal organizations (i.e., the Medical Group
Management Association (MGMA), the Center for Governance of the American Hospital
Association (AHA), Partnerships for Healthcare in Boston and others) to further disseminate the
joint work of the Advisory Board and the Department. Aspects of the Advisory Board’s
activities were also featured in an important story in Modern Healthcare.
Other contributions to the information technology debate at the national level include our work
with GetWellNetwork®, a privately held organization based just outside Washington, DC that is
committed to bringing the Internet to every patient’s hospital bed. Original research conducted
by the Department is seeking to demonstrate the power of bedside Internet access on quality of
medical care for inpatients, their level of satisfaction, and related outcome measures. We are
conducting similar activities with a Chicago-based firm and their key product, Care Pages.
On the Jefferson campus, our JUP performance measurement team is working closely with the
Allscripts Touchworks© electronic health record implementation team, to ensure that the EHR
system is aligned with national and local quality data reporting initiatives, and that clinical
Department record templates include appropriate quality indicators.
Coordination of Care
Other issues critical to improving care at the national level include improving care coordination,
especially for individuals with chronic diseases. Once again, the Department draws on its
various resources to consult with the private sector, publish research in scholarly peer-reviewed
journals, and hold national conferences regarding these activities. For example, the Chairman
continued to serve on the board of two publicly-held chronic care management (sometimes
called disease management) companies: Informedix (OTCBB:ISMX), based in Rockville,
Maryland, and the I-Trax Corporation in Philadelphia, Pennsylvania (AMEX: DMX). In
addition to the Chair’s activities, the Department serves as the editorial home for Disease
Management, the only peer-reviewed scholarly journal in the field of chronic care management
and improvement. Disease Management is also the official journal of the Disease Management
Association of America (DMAA), headquartered in Washington, DC. For the fourth consecutive
year, the Department hosted the annual Disease Management Colloquium in Philadelphia. This
meeting has outgrown its initial home on the Jefferson campus, and is now held at a major
downtown hotel, where it attracts more than 350 attendees and expert faculty from across the
nation. By connecting our research, education, and policy consulting agendas, we are able to
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influence the national conversation about the care of persons with a chronic illness. More about
these activities follows later in this report.
Improving Access
Certainly, improving access to medical care is another important national population and health
policy issue. This past year, the Department broadened its research agenda and continued in its
advisory role with Take Care Health Systems, a leading company in the convenient care arena
headquartered in Conshohocken, Pennsylvania. Take Care, recently purchased by the national
Walgreen’s drug store chain, is part of a new national trade association called the Convenient
Care Association (CCA). Convenient care, which promotes easy access to non-emergent
primary care delivered by highly trained nurse practitioners in a kiosk-like format inside chain
drug stores, is a “disruptive technology” that has changed the access-to-care landscape in the
United States.
One of the Department’s research divisions organized a group of Jefferson Medical College
faculty to review in detail the practice guidelines utilized by Take Care’s nurse practitioners.
This enabled Take Care to effectively promote cutting-edge, evidence-based practice, certified
by Jefferson Medical School faculty members. The Department is working with Take Care to
create a research agenda, helping them to further refine the outcome measures of the care they
are currently delivering across the country. The Chair also serves as the Chair of the national
Take Care Medical Advisory Board, which creates medical policy, reviews practice guidelines
utilized by the nurse practitioners, and helps inform the leadership of Take Care regarding
strategic issues for the future.
Within Philadelphia, the Department continues to work closely with community-based
organizations to address issues of access to appropriate, timely, high-quality care. Our ongoing
work with the Health Federation of Philadelphia has been examining the impact on
pharmaceutical access and compliance of a pharmacy access program in community health
centers. We also have begun to explore research collaborations with the Maternity Care
Coalition, Philadelphia Coordinated Health Care, and other community-based organizations to
evaluate strategies for improving care access.
Drug Safety and Cost-effectiveness
Improving the safety and cost-effective use of pharmaceuticals is another critically important
national quality and safety issue. The Department participates in these activities in a number of
different ways. First, the Chair is very active with the National Quality Forum (NQF) in
Washington, DC, and this past year led one of the critical technical advisory panels (or TAPs).
This particular TAP dealt with the appropriate use of pharmaceuticals in the ambulatory setting.
The work of the TAP filters up through the policy-making apparatus of the NQF. Payer
organizations, including the Center for Medicare and Medicaid Services (CMS), adopt many of
the recommendations from the NQF.
Faculty members within the Department made national news this year regarding their research in
the cost-effective and appropriate usage of Erythropoietin-Alpha (EPO-a). It was clear to senior
Departmental faculty that there might be inappropriate usage of this important, expensive
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product. Aspects of published research by our faculty received wide attention in the press.
Furthermore, one of our senior faculty members was invited to testify in front of Congress on
Capitol Hill regarding her research findings about the inappropriate use of EPO-a in dialysis
centers.
Finally, the Chair writes a monthly editorial in the national journal Pharmacy and Therapeutics.
P & T reaches an audience of nearly 60,000 across the United States on a monthly basis. This
publication provides a forum for the Department to influence the policy debate regarding the
appropriate use of medication and the cost-effective use of healthcare resources. Editorials this
past year have focused on a number of timely topics, including medication safety, the role of the
TAP, and inappropriate use of EPO-a.
Educational Symposia and Publications
The intersection of nationally important health policy issues, the research agenda of the
Department, and scholarly publications emanating from the Department is an important story.
Other aspects of the Department’s story this past year include the education and training
priorities as articulated in our mission statement. The Department continues to be the central
JMC clearinghouse for educational programming related to health reform, the safety of medical
care, and leadership training for the future. For example, in November 2006 the Department
created and hosted “Medicine 2020: Focusing the Vision of Medical Education,” a Dean’s
conference which attracted several hundred stakeholders to hear from leading medical educators
about the future of medical education. In January 2007, the Department hosted the third annual
Interclerkship Day, a full-day program devoted to patient safety exclusively designed for the
third year JMC Class. As the 2006-2007 academic year concluded, the Department was
preparing for the 13th Annual Summer Seminar, “Rx for Pennsylvania: Healing the Healthcare
System,” attended by over 225 persons, highlighting the growing political agenda for health care
reform in the Commonwealth. These important programs are recorded and made available via
podcast through the Department’s web site for those who were unable to attend in person.
Through the combination of live and asynchronous availability, these various educational
offerings disseminated the work of our faculty, reaching thousands of persons on and off our
campus.
Key publications that emanated from these activities were a highlight of this past academic year,
allowing the Department to link its educational agenda with scholarly publishing on the
outcomes of these various programs. A special article on the history and outcomes of
Interclerkship Day was published in the American Journal of Medical Quality, and an entire
issue of Disease Management focused on the Summer Seminar “Rx for Pennsylvania.” This past
year also heralded the publication of Practicing Medicine in the 21st Century, our multi-authored
edited text, which debuted during the “Medicine 2020” Dean’s program noted earlier. This book
became a national best seller almost immediately and has been deployed in schools of medicine,
public health, management, business, and law. Published by the American College of Physician
Executives (headquartered in Tampa, Florida), Practicing Medicine in the 21st Century is the
organization’s #1 Best Seller for this past academic year. The Department is committed to the
recognition that training the leaders of tomorrow is an important component of good leadership
today.
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Public Health Education
This past year represented a watershed in the development and maturation of the TJU Masters of
Public Health (MPH) Program. Currently, the MPH Program is accredited by the Council on
Education for Public Health (CEPH), with both full and part-time options leading to the MPH
degree. There are approximately fifty students enrolled in the program as of this writing. This
past year, this program was transformed from an MSPH adult learner, part-time only program to
a more nationally recognizable MPH curriculum.
This year we successfully recruited Rob Simmons, DrPH, MPH, CHES, a full-time national
public health leader, to serve as the director of the program. Dr. Simmons has over thirty years
of public health experience in government, health care, private foundations and community
health organizations and, most recently, had been a faculty member at both Drexel University
and West Chester University. Having been a founder and Past Board Chairperson of a number
of health organizations such as the Healthy Delaware Foundation and the American Heart
Association, Pennsylvania-Delaware Affiliate, Dr. Simmons is currently the President of the
Society of Public Health Education (SOPHE), the leading national public health education
organization in the nation.
Public health and the law are topics of national interest affecting many facets of society.
Demands for professionals with joint degrees have increased in recent years from hospitals,
health departments, health associations, non-profit organizations and businesses. The JD/MPH
and MJ/MPH degrees are designed to provide the knowledge and skills required to thrive in
health/law practice, advocacy and policy. They will benefit a wide range of healthcare and legal
professionals including nurses, policy makers, nursing home administrators, paralegals,
government employees, and private practice lawyers and litigators.
This year also saw the culmination of the creation of our joint program in law and public health
with Widener University’s School of Law. Specifically, Widener School of Law and TJU are
now pleased to offer two joint degrees, Juris Doctor/Master of Public Health (JD/MPH) and
Master of Jurisprudence/Master of Public Health (MJ/MPH), the only programs of their kind in
the Delaware Valley. One of the goals of this unique regional joint degree program is to place
our graduates at the forefront of the policy, regulatory, and insurance issues needed for a
successful career in public health law. This joint degree program was officially announced in
May 2007 at a joint press conference with the leaders of the Widener Law School and the MPH
Program at Jefferson. We already have successfully enrolled our first student in this new
program!
Another important aspect of the maturation of the MPH Program is the announcement of the
Jefferson Medical College five-year joint degree program, (the so-called MD/MPH option).
Recognizing the growing need for physician leaders who want to “make a difference” in the
health of our communities and to develop competencies in population and community health,
Jefferson University is now offering an MD/MPH combined degree program. The program will
allow medical students at Jefferson Medical College to take “a full year plus” in public health to
obtain an MPH degree in conjunction with their medical school education. After the second or
third year of medical school, MD/MPH students will take a year of courses in public health that
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include a short community-based public health experience (clerkship) and a final capstone
research project. The capstone may be completed in the summer of the year out or during
elective time in the final year of medical school.
We are confident that physicians and public health professionals with both the MD and MPH
degrees will have an expansive career track available to them, including the administration of
state and local public health departments or health centers, health insurance organizations,
consulting activities, international programs, nongovernmental health organizations, academic
positions with either a clinical or research focus, the pharmaceutical industry and, of course,
clinical health practice serving our most needy populations. With the announcement of the joint
MD/MPH Program at Jefferson, national leaders from the AAMC came to campus in the
summer of 2007 to review the more than forty existing MD/MPH Programs and to give us advice
on the design and operation of our program.
While Dr. Simmons will serve as the day-to-day director of the MPH Program, the Department
Chair continues to serve as co-Chair of the MPH Steering Committee along with the Chairman
of the Department of Family and Community Medicine at JMC. Future plans for the MPH
Program include the possible development of various certificates in health policy, quality, and
patient safety. In addition, the new Jefferson School of Pharmacy and School of Nursing will
have formal articulation agreements with the MPH Program. It is hoped that many of the more
than 3,000 students on the campus of TJU will avail themselves of the opportunity to obtain an
additional degree in public health while advancing their careers.
The Department of Health Policy also was honored this year to be selected by the national Albert
Schweitzer Fellowship Program to launch a regional program in the Philadelphia region. The
Schweitzer Fellowship provides an opportunity for graduate students in health-related disciplines
to develop their interests and skills in community service through designing and conducting a
year-long service project. The Delaware Valley Schweitzer Fellows Program is the first program
expansion site in several years, joining five previously established programs throughout the
country. Our service area includes Philadelphia and suburbs, Delaware, and southern New
Jersey (Camden and Burlington counties). While the program is administratively housed at
Thomas Jefferson University, it is open to students throughout the service area. In the program’s
first year, twelve fellows were selected, and are currently engaged in their service programs,
addressing issues such as health education, violence prevention, eliminating healthcare
disparities, access to care for the uninsured, environmental health, and parenting skills.
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A. Education
Overview
The Department’s education team includes one faculty member, 3 project directors, 2 medical
writers, and 3 education support staff. We are currently recruiting for an additional senior-level
project director, whose activities will be primarily directed to the development of special
graduate education programs. The team’s work is devoted to the following types of activities:
•

Educational programming for JMC – this includes courses, mentorships and special
programs for medical students, residents, and fellows.

•

Contracted educational programs for pharmaceutical companies – these programs are
non-product-related, devoted to education regarding specific disease states, and
quality and patient safety issues.

•

Advisory Boards – these boards, which can be devoted to strategic, clinical or
research-related topics, are organized by the team and facilitated by the Chair.

•

Conferences and symposia – the team is often contracted to organize, develop and
manage professional conferences and symposia for both internal and external clients.

•

Continuing Education – the Department serves as the official TJU provider of
continuing education credit for pharmacists.

•

Education programs for Jeffersonians – regularly scheduled programs on topics of
interest to the general Jefferson community.

•

Specialized education programs – customized education programs for healthcare
professionals, both clinical and administrative, that are focused on quality
improvement and value-based purchasing of health benefits.

•

Publications – the team is responsible for the regular production of four national
scholarly journals, a quarterly newsletter, and the creation of enduring materials
related to some of the educational programs produced by the Department.

Current Funded Education Projects
The following list summarizes educational grants active in the Department of Health Policy at any time
in the 2006-2007 academic year. The status column indicates whether the grant remained open as of
the end of the year. More information on these grant-funded programs, and other education programs
for Jefferson students, and external audiences, follows.
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Title and Brief
Description
Clinical Training Practica
for Pharmacy Reps
(Includes programs for
clinical training in
cardiovascular, diabetes,
HIV, migraine,
osteoporosis and
respiratory; amended to
include additional
programs on hospital
quality improvement)
Practicing Medicine in the
21st Century – editorial
management and content
development
Advisory Board on
Atypical Antipsychotic
Medications (Meeting #6)
Advisory Board on
Atypical Antipsychotic
Medications (Meeting #7)
Bridging Care Planner
Special Issues Board on
the Use of Disease
Registries
Disease Management
Colloquium

Investigators

Source of Support

Total Amount

A. Skoufalos

Merck & Co.

$ 750,276

Status as of
6/30/07
Open

A. Skoufalos

American College of
Physician Executives

$

8,000

Completed

D. Nash

Bristol-Myers Squibb

$

84,000

Completed

D. Nash

Bristol-Myers Squibb

$

84,000

Completed

D. Nash

GlaxoSmithKline

$

42,800

Completed

D. Nash,
A. Skoufalos

Davis Wright Tremaine

$

25,000

Rx for Pennsylvania –
Healing the Healthcare
System Symposium
Core I and II Vaccine
Training
Health Information
Technology Advisory
Board (Meeting #3)
Health Information
Technology Advisory
Board (Meeting #4)
Education Series on
Evidence-Based Medicine
Medicine in 2020:
Focusing the Vision of
Medical Education
Disease Management
(Journal)

A. Skoufalos

Pennsylvnia Department
of Aging

$

67,200

Open; will
renew for
2008
Open

D. Nash

GlaxoSmithKline

$

33,400

Completed

D. Nash

InterComponentWare

$

75,000

Completed

D. Nash

InterComponentWare

$

75,000

D. Nash,
A. Skoufalos
D. Nash

Ortho McNeil
Pharmaceuticals
JMC Dean’s Office

$

54,000

Open;
renewing for
Meeting #5
Completed

$

52,000

Completed

D. Nash

Mary Ann Liebert

$

42,000

American Journal of
Medical Quality
(Journal)

D. Nash

American College of
Medical Quality

$

98,100

Open;
renewing for
an additional 3
years
Open
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Title and Brief
Description
P&T
Biotechnology Healthcare
(Journals)
Interclerkship Day
Program 2007
Day in the Hospital
Pharmacy Training
Advisory Board on
Diabetes and Medicare
Part D
Advisory Board on
Creating a New Prevention
and Wellness Service
Model
Quality Improvement
Roundtable Discussion
with Publications
Leadership Strategies for
Quality and Performance
Improvement Symposium
Supplement to AJMQ re
Managing Complex CoMorbid Conditions
Supplement to Disease
Management re DMAA
Obesity Summit
Supplement to Disease
Management re Chronic
Care at the Crossroads
CME Program “21
Strategies to Survive in the
21st Century”
Supplement to Disease
Management re Prevention
DM Audioconference –
Variations in Healthcare:
A Conversation w/Jack
Wennberg
Health Policy Forums –
unrestricted educational
grant to support costs
Newsletter Series on
Migraine (Pharmacy
Credit)
Emergency Preparedness
Training (Pharmacy
Credit)
TOTAL

Investigators

Source of Support

Total Amount

D. Nash

Medi-Media

$ 120,000

D. Nash

JMC Dean’s Office

$

A. Skoufalos

Merck & Co.

$ 213,500

Completed;
renewing
Open

D. Nash

Novo Nordisk

$ 118,000

Completed

D. Nash

US Preventive Medicine

$ 375,000

Open

A. Skoufalos

Eli Lilly & Co.

$ 270,000

Open

D. Nash

Premier/CareScience

$

40,000

Open

D. Nash,
A. Skoufalos

Schaller-Anderson

$

30,000

Completed

D. Nash,
A. Skoufalos

Disease Management
Association of America

$

30,000

Open

A. Skoufalos

Intel Health Group

$

30,000

Open

A. Skoufalos

Pennsylvania Academy
of Family Physicians

$

15,000

Open

A. Skoufalos

US Preventive Medicine

$

30,000

D. Nash

Davis Wright Tremaine

$

5,500

Completed

D. Nash

Pfizer

$

5,000

Open

A. Skoufalos

INCE

$

8,000

Open

A. Skoufalos

Philadelphia Medical
Reserve Corps

$

8,000

Completed

50,000

$2,595,776
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Status as of
6/30/07
Open

1. Medical Students
a. Interclerkship Day: In January 2007, the Department organized and presented the 4th JMC
Interclerkship Day program, Improving Patient Safety, featuring two nationally prominent
experts: John J. Nance, JD, founding board member of the National Patient Safety Foundation
(NPSF) and aviation safety expert, and Judith A. Owens, MD, MPH, Director of the Pediatric
Sleep Disorders Clinic at Hasbro Children’s Hospital at Brown University School of Medicine
and Chair of the American Academy of Sleep Medicine’s Sleep, Alertness and Fatigue
Education in Residency (SAFER) Task Force. The program addressed many of the barriers to
incorporating patient safety and quality improvement tools in the inpatient setting, prompted
students to think of ways in which the culture at Jefferson could be changed to promote greater
patient safety, and emphasized the need to utilize a systems approach with full support from
leadership, management, providers, and staff to comprehensively address and reduce problems
and errors. Outcomes of the program were published in the American Journal of Medical
Quality.
b. Summer Internship: The Department continued to serve as a training site for medical
students who completed the freshman year and were selected to participate in the Dean’s summer
internship program. This year’s (2006) student, Kathryn (Karisa) Walker, researched topics in
medical education and health policy, which culminated in her co-authorship with the Chairman
of a chapter in the multi-author text, Practicing Medicine in the 21st Century.
c. Academic Year Internship: The Department has gained a reputation as a training site for
medical students who are completing requirements for the MBA program. The Department
welcomed Eric Moskowitz and Jeffrey Clough, both Jefferson students participating in the joint
MD/MBA program with Widener University, as academic interns. Eric and Jeff participated in
research and education projects (e.g., the online residency training program sponsored by the
American Headache Society; several medical advisory boards), attended the national MD/MBA
conference, and worked to rejuvenate student interest in the joint program. They were also coauthors of different annotated bibliographies that were published in the American Journal of
Medical Quality. Eric co-authored the article on graduate medical education competencies; Jeff
co-authored the article on health care governance for quality and safety.
d. Policy Electives
• HPOL499 – Independent Study: In March of the JMC senior year, the Chairman
conducts a one-month graduate-style elective in health policy. This year students read
The Quality Solution, co-edited by the Chair and Neil Goldfarb, Vice Chair for Research.
This book was critically reviewed by the students with the Chair’s guidance. The Chair
also continues to serve as the faculty advisor of the JMC student club, “Physicians of
Tomorrow.”
• HPOL401 – Introduction to Health Policy: This second fourth-year elective was
offered twice in the spring of 2007. The one-month course is taught by Neil Goldfarb and
Laura Pizzi, Division Director of Pharmacoeconomics and Outcomes Research. It
provides an overview of current issues in health policy, including health care financing,
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access to care, quality and safety improvement, and technology assessment. The elective
will continue to be offered in three tracks each year.
e. MD/MBA Program: It is widely acknowledged that physician training in management skills
must improve. Indeed, a growing body of literature specific to the physician manager is available
and is actively tracked and contributed to by the Department. Currently 12 JMC students are
enrolled in the unique five-year MD/MBA training program, co-directed by JMC through the
Department of Health Policy and Widener University. This year saw the graduation of the eighth
cohort of students from the combined degree program. Not surprisingly, the JMC MD/MBA
students have proven to be academic standouts within both the undergraduate medical and
graduate business curricula. The students, faculty, and administrators responsible for directing
this program meet twice during the academic year to review progress and make plans for future
enrollees. A research agenda regarding a longitudinal study of their attitudes, knowledge, and
beliefs is currently underway, in collaboration with the JMC Center for Research in Medical
Education.
2. Graduate Students
As noted in the “General Overview” section at the beginning of this report, the Department hired
a Director for the Masters of Public Health program in the College of Graduate Studies, and
continues to have a leadership role in program expansion and improvement. Department faculty
also teach many of the courses offered to MPH and other CGS students.
a. Courses
• GC515 – Quality Measurement and Outcomes Analysis in Health Care: This
course, cross-listed with University of the Sciences in Philadelphia, now in its sixth year,
is led by Neil Goldfarb, Vice Chair of Research. Guest faculty are drawn from the
Department, and the Jefferson and Delaware Valley communities.
• GC650 – Economic Evaluation of Healthcare Technologies: This course (formerly
titled “Pharmacoeconomics”) is led by Laura Pizzi, PharmD, Division Director of
Pharmacoeconomics and Outcomes Research and Thomas Bunz, PharmD, Research
Instructor.
• GC660 – Statistical Methods for Data Analysis: This course was offered in the fall
of 2006, and in the spring and summer of 2007, under the leadership of Albert Crawford,
Assistant Professor. Dr. Crawford was assisted by Diane Richardson, PhD, Research
Instructor, in the fall and spring; Dr. Richardson is serving as the lead instructor of the
course during the summer.
• PH506 – Health Services Research Methodology: This course was offered in the
spring of 2007, under the leadership of Jennifer Lofland, PharmD, MPH, PhD. Many of
the individual sessions are taught by members of the Department’s research staff and
other guest faculty. Kathryn Kash, PhD, will assume leadership for the course for its next
offering in spring of 2008.
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• PH508 – Health Policy: An International Perspective: This new course on
international policy, developed by Vittorio Maio, PharmD, MPH, Research Assistant
Professor of Health Policy, in collaboration with Daniel Louis, MS, Managing Director
of the Center for Research in Medical Education, was offered for the first time in Spring
2007.
A proposal was accepted for a new course in the MPH program, Introduction to GIS Mapping, to
be led by Elaine Yuen, PhD, beginning in 2008.

3. Fellows
a. Outcomes Research Fellowship Programs
The Department continues to serve as a training site for outcomes research fellowships. During
2006-2007, fellowships were sponsored by Ortho-McNeil Janssen Scientific Affairs, LLC, and
GlaxoSmithKline. Fellows who participated in this program are PharmD- or MD-trained
clinicians. Collaborations such as these have resulted in numerous published studies and posters
for presentation at national meetings. In June 2007, the Chair hosted the Seventh Annual
National Fellowship Advisory Council, a group of more than 29 former Department fellows, in
Philadelphia, PA. The National Advisory Council provides overall strategic direction for the
fellowship program. Alumni of the fellowship program are often a source of research support for
the Department.
b. Delaware Valley Schweitzer Fellows Program
As discussed earlier, since September 2006, the Department has served as the home of the
Delaware Valley Schweitzer Fellows Program (DVSFP). This prestigious program provides
stipend support to students in degree-conferring programs who have an interest in community
service. In this, the inaugural year of the program, 12 Fellows were selected from academic
programs in the region and they are actively implementing their projects in Philadelphia and its
suburbs, Southern New Jersey, and Delaware. More information on the DVSFP and current
projects is available at www.schweitzerfellowship.org/features/us/del.
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4. Residents
a. Residency training
The Chair continues to be involved in clinical training through his outpatient practice activities
and time spent on the teaching service at TJUH. Dr. Nash serves as an advisor to the Residency
Program Directors in Internal Medicine as they plan their pay-for-performance program. He and
other Department faculty have been featured speakers during several of the Family Medicine and
Internal Medicine residency noon conference programs.
The Department of Medicine has created 8 career pathway tracks for residents in Internal
Medicine; these are detailed in a newly published brochure, “Personalized Career Pathway: An
individualized approach to training in Internal Medicine for the new Millennium.” The Chair
serves as the coordinator for the MBA/MPH/Robert Wood Johnson Clinical Scholar track.
One of the Department’s joint education/research projects involved refining an online training
program on headache for neurology residents. The Department helped to refine the content so
that it was aligned with all of the GME competencies. Residents from Jefferson’s neurology
program were involved in some of the pilot testing of items prior to the full project launch.

5. Other Educational Programs and Audiences
Pharmaceutical Training
Many area pharmaceutical companies are interested in providing both basic and advanced
training for their sales and national account representatives on various topics, including specific
disease states, improving patient safety, and issues surrounding quality improvement. By
developing non-product-related educational programs, the Department is contributing to the
transformation of the detail sales force consistent with evolving ACCME policies. This is a key
cultural change, and is crucial in creating an appropriate atmosphere and relationship between
academic medicine and pharma. The Department is pleased to be at the forefront of fostering
innovation and change. Below is a list of the various programs offered by the Department during
the 2006-2007 academic year.
a. Asthma: Merck sales representatives and product managers completed a full-day clinical
practicum on asthma and allergic rhinitis. As part of this program, the participants toured the
pulmonary lab, experienced pulmonary function tests, were shown laboratory specimens, and
interacted with primary care physicians and specialists. This program has been offered seven
times during the 2006-2007 academic year; additional dates are planned for the remainder of
2007 and into 2008.
b. Cardiovascular: This is another in a series of full-day clinical practicum training programs for
Merck sales representatives and product managers. Participants receive a combination of didactic
and experiential training (including demonstrations in the cardiac catheterization lab and
ultrasound), have the opportunity to interact with primary care physicians and specialists, and are
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afforded a question and answer period. The program familiarizes the participants with the
diagnosis, treatment and management of cardiovascular disease. It was offered twice during the
2006-2007 academic year.
c. “Day in the Hospital”: This program, piloted in August 2006, was designed for Merck sales
representatives who call on hospital pharmacies. The goal is to provide an overview of: hospital
governing structure and procedures, the role of the hospitalist, how the P&T committee is
organized and reviews items for consideration, and how a hospital pharmacy is structured to
support and coordinate patient care. The program was offered four times during the 2006-2007
academic year, and is scheduled to continue through 2007 and into 2008.
d. Diabetes: Merck sales representatives and product managers completed a full-day clinical
practicum on diabetes. As part of this program, the participants were shown laboratory
specimens and interacted with primary care physicians, specialists, and related health
professionals. The program placed special emphasis on the team approach to management and
treatment. This program has been offered a total of six times during the 2006-2007 academic
year; additional dates are planned for the remainder of 2007 and into 2008.
e. Evidence-Based Medicine - Fall 2006 Educational Series: An educational program was
designed for a variety of special audiences for Ortho-McNeil Janssen Scientific Affairs and other
affiliated departments of Johnson & Johnson (J&J) on the topic of evidence-based medicine.
Johnson & Johnson has recognized that the changing health care landscape has a tremendous
impact on its business model, and wanted to ensure that its employees, especially those working
in clinical trials and pharmaceutical marketing, have a good understanding of how it works.
A two-part, half-day session was delivered twice (once in Raritan and once in Titusville). Over
100 participants attended an educational program that featured the Chair and the Vice Chair for
Research. The sessions were videotaped and archived to be made available to employees from
other J&J locations who were unable to attend. Two DHP-edited texts, The Quality Solution and
Economic Evaluation in US Health Care: Principles and Applications, were among the required
reading preparation for the program participants.
f. HIV: Merck sponsored a program for their specialty reps in the infectious disease and vaccine
areas on HIV. The two-day program included presentations from clinicians and representatives
from a local AIDS support program, so that participants were able to understand the full impact
of the disease from both a clinical and social perspective. The program was offered twice during
the academic year.
g. Migraine: Merck sales representatives and product managers completed a full-day clinical
practicum on migraine. The participants toured the headache center and interacted with primary
care physicians and a variety of specialists (i.e., neurologist, emergency medicine, OB/GYN, and
psychiatrist) who treat patients with migraine. The program was offered in January 2007.
h. Osteoporosis: This program was designed for newly hired Merck sales representatives, with
no prior health care experience, who call on those primary care physicians referring patients to
rheumatology and/or gynecology. The goal was to prepare the sales representatives for the
complex and dynamic health care environment by providing hands-on experience and helping
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them to gain understanding where products fit and how they are utilized. Participants were
exposed to the hospital organization, the responsibilities of the key personnel within each
division, and the interdisciplinary approaches to diagnosis of disease states. The program was
held twice during the academic year.
i. Hospital Quality Improvement: Merck requested a program for their regional sales forces (to
be rolled out nationwide) on the topic of hospital quality improvement. The sponsors objective
was to educate their account representatives on the various quality improvement initiatives,
reporting requirements and pay for performance programs being rolled out by health plans and
the federal government. The program included both live and videotaped sessions by the Chair
that provided an overview of the national quality landscape.
j. Vaccines: GlaxoSmithKline sales representatives practiced their detailing skills with a
simulated medical office team composed of a family practitioner, nurse, office manager, and
pediatrician. This experience provided the representatives with insight into the different roles and
perspectives of the various members within an office setting. During the second phase of their
training, the sales representatives met with an immunization specialist from the Pennsylvania
Department of Health, who discussed how vaccines are used in the Philadelphia area from a
public health perspective (child and adult schedules). An infectious disease specialist presented
case studies on the use of vaccines in the hospital. This combination of programs was offered
twice in the 2006-2007 academic year.

Advisory Boards
Due to the Department’s specialized capabilities, and the Chair’s national reputation as an expert
in the area of quality, the Department is often called upon to organize advisory boards. Through
our efforts in reruiting and facilitating these boards, the Department is able to expand its already
considerable national network, contribute to its research portfolio, and enhance both the
Department’s and Jefferson’s reputations. The boards are generally categorized as clinical,
strategic, or technical (or some combination) and can cover a variety of topic areas, such as
wellness and prevention, health information technology, and pharmacoeconomics. Below is a
list of advisory boards organized by the Department and facilitated by the Chair in the 20062007 academic year.
a. Adherence and Persistence: The Department of Health Policy and GlaxoSmithKline founded
The National Advisory Board on Adherence and Persistence, the purpose of which was to draft a
list of recommendations regarding adherence and persistence in order to develop a consensus
statement on future directions for related health care research and policy. Subsequent to The
National Advisory Board meeting were five Special Issues Boards, regionally convened groups
of employers who addressed the issues associated with adherence and persistence in their
employee populations. The final product of the five board meetings is a one-hour CD, hosted by
the Chair, featuring national policy experts in the area of adherence and persistence. The CD was
advertised for purchase in various human resources trade publications in the spring of 2007, and
was distributed to all attendees at the 2007 Disease Management Colloquium.
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b. Atypical Antipsychotics: The Department serves as host, and the Chair as facilitator, for the
ongoing Atypical Antipsychotics Advisory Board supported by Bristol-Myers Squibb. The
Board, composed of nationally recognized experts in the fields of psychiatry, Medicaid, and
managed care, met twice during the course of the academic year. The Board convened for the 6th
time in October 2006 and the 7th time in April 2007 to address new findings in the field. They
are scheduled to meet again in the spring of 2008.
c. Diabetes and Medicare Part D: The Department serves as host, and the Chair as facilitator,
for the Changing Diabetes Initiative Advisory Board supported by Novo Nordisk. The Board
met for the first time in October 2006, when it brought together various stakeholders with an
interest in how the advent of Medicare Part D would affect dual-eligible beneficiaries. The
Board included clinicians, policy experts, and representatives from CMS and managed care. The
Department developed a risk assessment tool for use by Novo Nordisk in identifying individuals
at increased risk of developing diabetes. The Board was scheduled to meet again in the fall of
2007, and again in 2008.
d. Disease Registries: The Department hosted a special issues board on the use of disease
registries to improve care coordination and management in physician practices, facilitated by the
Chair. The board was sponsored by GlaxoSmithKline’s Outcomes Research Group. The meeting
was held in Philadelphia in September 2006; no follow-up meeting has as yet been scheduled.
e. Health Information Technology: The Department serves as host, and the Chair as facilitator,
for the ongoing National Advisory Board supported by the US branch of InterComponentWare
(ICW), a technology company headquartered in Germany. The Board, composed of nationally
recognized experts in the field of health information technology, met in November 2006. The
Board planned to meet with the parent company’s International Advisory Board at a special
summit in Berlin in July 2007 to address new findings in the field.
f. Prevention and Wellness: In December 2006, the Department hosted, with the Chair as
facilitator, the second meeting of the National Advisory Board for US Preventive Medicine
(USPM). USPM is working to create a new model to deliver preventive and wellness care, and
has assembled a diverse group of stakeholders and experts. The proceedings from the group’s
first meeting were chronicled in a special supplement to Disease Management. The group is
rolling out a prototype model this fall, and hopes to schedule its 2008 meeting soon.
g. Quality Improvement: In March 2007, the Department convened a special roundtable
discussion group to review various quality improvement strategies that affect the general national
landscape and both the hospital and ambulatory care settings. The program was sponsored by Eli
Lilly & Company, and was an invitation-only event. The goal was to provide a forum for some
of the pre-eminent experts in quality to discuss and review specific projects and programs that
could serve as models. The connection with the participants from the forum has already led to
the development of proposals for research in the areas of error reporting, EMR implementation,
and implementation of quality improvement projects.
The ultimate outcome of the forum was to create articles that would comprise four separate
supplements to the Health Policy Newsletter, and be disseminated to interested groups across the
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country. During the summer, the medical writing staff and the Vice Chair for Education are
working with the participants to develop their articles and create the pilot issue. The initial
supplement was scheduled to be published in September 2007, with the remainder scheduled for
publication in December 2007, and March and June 2008. This type of educational forum, and
the resulting dissemination of enduring materials to a broad audience, has the effect of spurring
discussion and encouraging the examination of data that has the potential to transform quality
improvement initiatives nationwide.

Conferences and Symposia
The Education staff have been called upon by internal and external clients to create local, state
and national professional conferences and symposia, providing expertise in content development,
faculty recruitment, marketing, and conference management services.
a. Medicine 2020: Focusing the Vision of Medical Education: The Department was asked to
organize this special conference, sponsored by Dean Thomas J. Nasca, to provide a national
forum to discuss the ways in which we must reform the education of medical students to meet
the demands of the 21st century. Speakers from Stanford, AAMC, ABIM and other key
stakeholders spoke to an audience of over 200 participants. Copies of Practicing Medicine in the
21st Century were provided to the attendees.
b. Disease Management Colloquium: For the fourth consecutive year, the Department hosted
the Disease Management Colloquium, the only executive education course on the role of disease
management in Medicare, Medicaid, health care cost efficiency, quality and medical error
reduction. The program has become so popular that it has been permanently moved off the
Jefferson campus to the Hyatt Penns Landing Hotel. Over 300 attendees (including several from
foreign countries) participated in the three-day program that featured more than 60 national
experts in disease management. The Disease Management Editorial Board met for its annual
dinner and business meeting during the second day of the symposium.
th

c. Rx for Pennsylvania: Healing the Healthcare System: The 13 Annual Summer Seminar is
focused on Governor Rendell’s proposed health care reform program, “Rx for Pennsylvania.”
The program is sponsored by the Pennsylavnia Department of Aging, and features Secretary of
Aging Nora Dowd Eisenhower and Rosemarie Greco, Director of the Governor’s Office of
Health Care Reform. Over 225 participants from across Pennsylvania and the region plan to
come together to discuss the impact of our increasing aging population on health care access,
clinical practice, and service delivery models. One of the highlights of the program is a
roundtable discussion on how to bridge the gap between the vision and implementation of the
reform program. The roundtable features representatives from various stakeholder groups
including consumers, payers (government and private), and providers (Pennsylvania Academy of
Family Physicians and Main Line HealthCare). The panel discussion will be moderated by the
Chair and preserved in the form of a podcast (available for download from the DHP web site).
WHYY will capture the roundtable session on videotape for later broadcast on their Wider
Horizons network. Last but not least, the December 2007 issue of Disease Management will
feature articles on the topic authored by the principal speakers from the program.
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Continuing Education Programs
Collectively, the members of the Education team have many years of professional and practical
experience in designing and implementing continuing education programs for a variety of
audiences.
a. Continuing Medical Education: The Department continued its outstanding collaborative
relationship with the Office of Continuing Medical Education. The Department continues to
provide the second-highest-grossing CME activity within JHS. During the 2006-2007 academic
year, the Vice Chair for Education was appointed to serve on the JMC-CME Committee.
Further, in keeping with the new initiative to provide CME credit for quality improvement
efforts, the Department is helping to introduce this effort within JUP-CCC.
b. Continuing Pharmacy Education: The Department serves as an approved provider of
continuing education for pharmacists through the American Council on Pharmaceutical
Education (ACPE). The Department is the only approved provider on campus and works closely
with other Departments to maximize their continuing education programs. The Department was
successfully reaccredited to provide CE to pharmacists.

Education Programs for Jeffersonians
As part of the Department’s education mission, we endeavor to provide a variety of regularly
scheduled programs of interest to the campus community at large, with a focus on policy issues.
a. Health Policy Forum: The Department continued to conduct the Health Policy Forum, now in
its 17th year. The Forum has become a fixture in the scholarly life of the University. It meets on
the second Wednesday morning of every month (except July and August) and provides an
opportunity for all Jeffersonians and area professionals interested in health policy to congregate
and share their research experiences. This past year, the Department sponsored such guests as:
Tom DeSanto, JD, Executive Vice President of Aloysius Butler & Clark; James O’Hara, Director
of Policy Initiatives and the Health and Human Services Program at Pew Charitable Trusts;
David Smith, PhD, Professor of Risk Insurance and Healthcare Management at Temple
University; Warren Ross, MD, Senior Client Partner for Academic Health Center Practice at
Korn/Ferry International; Charles Elson, JD, Director of the Weinberg Center for Corporate
Governance at the University of Delaware; Nora Dowd Eisenhower, JD, Secretary of the
Pennsylvania Department of Aging; Richard Miller, MBA, President and CEO of Virtua Health;
and Jeff Gruen, MD, MBA, President of Revolution Health Group. Total attendance at the
Forum exceeded 350 participants in the past year.
b. Grandon Lecture: John G. Reiling, PhD, MHA, MBA, President and CEO of Safe by Design,
delivered the 16th Annual Raymond C. Grandon Lecture in May 2007. His presentation, “Patient
Safety: The Impact of Facility Design” detailed the ways in which patient safety can be
improved by “designing out” the errors, such as by ensuring there are handwashing facilities in
each patient room and placing nursing stations close to patient areas.
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The Jefferson community had specialized access to Dr. Reiling for the entire day of his visit. The
morning began with an invitation-only Ambulatory Care Breakfast Summit with the leadership
of Jefferson University Physicians, where Dr. Reiling was featured at a roundtable discussion.
The meeting’s agenda focused on creating a culture of safety and a review of the plans for
Jefferson’s new Ambulatory Care Center. After the summit, Dr. Reiling met with members of
the Department to discuss patient safety and ways to reduce medical errors. He then delivered
the Grandon Lecture, and answered questions from the audience and from the members of the
Jefferson reactor panel. The Chair has been appointed to the Boca Raton Community Hospital’s
National Advisory Council, a group created by Dr. Reiling to assist him in designing the “safest
hospital in the nation,” in Boca Raton, Florida.

Specialized Education Programs
a. Accelerating Best Care in Pennsylvania: See “General Overview” section above for
information on this hospital quality and safety improvement program.
b. American College of Physician Executives (ACPE – Tampa, FL): The Department was
involved in the further refinement of “Interact,” the web-based course sponsored by the
American College of Physician Executives (Tampa, FL). The Chair produced and filmed an
updated two-CD course, titled “The Three Faces of Quality,” for physician executives
throughout the United States. It continues to be offered six times per year in an asynchronous
fashion through a secure web site with streaming video and simultaneous full printed text of the
lectures. The online classroom experience is facilitated by the Chair and two additional
nationally prominent faculty members. Comprehensive surveys indicate that this course is very
well received.
c. College for the Advanced Management of Health Benefits: In collaboration with the
National Business Coalition on Health and the HealthCare21 Business Coalition in Tennessee,
the Department launched the College for Advanced Management of Health Benefits (CAMHB)
in 2004. CAMHB is designed to train employee benefit managers, other corporate executives,
brokers and benefits consultants on the concepts of “value-based purchasing” of health benefits.
A value-based approach to buying benefits is central to the DHHS vision for the future of health
care articulated by Secretary Leavitt, and is being incorporated into reimbursement systems for
CMS (Medicare and Medicaid) and other large purchasers and payers. Three three-day CAMHB
sessions were held over the past academic year, training over 100 participants. Evaluation
activities being conducted by the Department’s research staff demonstrate a positive response to
the program content and concepts, and significant change in benefits policies within the
participants’ organizations.
d. Pennsylvania Academy of Family Physicians: The Pennsylvania Academy of Family
Physicians (PAFP) approached the Department early in 2007 to create a special CME program
that could be taken “on the road” for their members around the state. The program, “21
Strategies to Survive in the 21st Century,” is based on the recently published text, Practicing
Medicine in the 21st Century, and was delivered at ten different locations throughout
Pennsylvania. The Vice Chair for Education and Drs. Jacoby and Sarfaty, two DHP faculty
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members, collaborated with PAFP to develop the program objectives, create the slide deck, and
coordinate content delivery between the two designated presenters (one from PAFP, one from
DHP).

Enduring Materials (Proceedings of Education Programs)
In addition to overseeing the production of publications of the Department, which are addressed
in a separate section of this report, the education team is responsible for developing and
preparing manuscripts based on some of the programs delivered during the course of the year.
Supplements, newsletter articles, monographs, and journal articles serve as enduring materials
for the proceedings of key meetings (e.g., Preventive Medicine: A “Cure” for the Healthcare
Crisis, U.S. Preventive Medicine Advisory Board Meeting, Disease Management,
November/December 2006; and Building Bridges: Managing Challenging Complex Co-Morbid
Conditions, Proceedings from a Symposium at Schaller-Anderson, American Journal of Medical
Quality, March/April 2007), clinical discussions of new treatments, and presentations of national
policy issues. The Department has three medical writers who regularly attend local, regional, and
national meetings to report on important issues and trends.
Future of Educational Programs
The Department will continue to offer a diverse range of programs across the spectrum of the
medical education curriculum, and to other regional and national audiences. Several
opportunities for increased involvement and support of JMC’s efforts exist and will continue to
be explored.
On the undergraduate level, the Interclerkship Day on patient safety was extremely well received
and the program is being revised for January 2008. We recognize that medical students would
benefit from more exposure to non-traditional subjects such as health policy, quality
improvement, error reduction, evidence-based practice, and public health. We will work with
JMC leadership to explore other opportunities, such as assuming responsibility for an additional
Interclerkship Day, perhaps with other disciplines (nursing, pharmacy, OT/PT).
Opportunities also exist to expose residents to these same topics and issues on the graduate
education level. Leadership, especially as it applies to implementing quality improvement and
patient safety initiatives, is a key subject area to explore at the graduate level. The Department is
committed to exploring opportunities to improve education at all levels in order to better prepare
physicians for the coming changes in health care.
Finally, we will continue to support the Medical College’s faculty development program by
offering support for training programs on policy, performance measurement and improvement
and other relevant topics.
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B. Research
Overview
The Department’s research team includes 12 faculty members, 10 research support staff, and 2
full-time research fellows. At any one time, this team is engaged in approximately 30 projects.
The team is organized into four main divisions:
•

Quality measurement and improvement – looking at issues related to health care quality
and safety, including development of new measures, and evaluation of programs intended
to improve quality and safety. This team also oversees ambulatory care performance
measurement and improvement for the Jefferson University Physicians (JUP) outpatient
practices.

•

Health services and health policy research – evaluating interventions and policies
addressing health care access, delivery, and finance, and disseminating best practices.

•

Public health education and research – developing opportunities for MPH students to gain
research experience, developing an agenda for community-based research, and
overseeing the Delaware Valley Schweitzer Fellows Program.

•

Pharmacoeconomics and outcomes research – conducting economic evaluation of new
drugs and devices, developing economic models, and measuring outcomes associated
with pharmaceutical interventions.

The Department’s research mission, as noted in the introductory section of this report, is broad,
and encompasses seeking solutions to many of the challenges facing the health care system in the
United States and overseas. Within this generalist framework for research, specific areas of
expertise which are represented among the research faculty and staff include (but are not limited
to):
•

Conducting pharmacoeconomic evaluations, including development of economic models

•

Development and evaluation of disease management programs and other health
management interventions

•

Designing and testing quality and safety measures and measurement systems

•

Evaluating the impact of health information technology and IT interventions

•

Conducting retrospective analysis of large claims and health record datasets, and
national research datasets

•

Collaborating with community-based organizations to evaluate the impact of policies
and programs on client care and health outcomes

•

Measuring health outcomes, including employee productivity, in the workplace, and
designing effective value-based benefit strategies
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•

Evaluating the impact of educational programs on providers, policy decision makers, and
consumers

In order to further foster the Department’s research mission in the past academic year, two
research interest groups were formed:
•

Cancer Policy and Outcomes Interest Group: was formed to promote research on the
policy dimensions of cancer care. Tying in closely with the University’s strategic plan,
the group’s goal is to work with cancer researchers at Jefferson and in the broader policy
environment to conduct research and disseminate findings, so as to improve the quality
and cost-effectiveness of cancer care. Areas of interest include, but are not limited to:
o The cancer patient’s needs from and perceptions of care
o Improving access to and effectiveness of cancer screening and prevention
o Measuring and improving outcomes of cancer care
o Assessing the direct and indirect (productivity) costs of screening and treatment
interventions
The group seeks to apply this expertise to cancer policy questions such as:
o How does cancer impact on quality of life for the patient and family members?
o How can patient and family member decision making among treatment or
screening options be facilitated?
o How can pain management and palliative care be improved?
o Which screening, diagnosis, and treatment interventions are most cost-effective?

•

Employer Research Interest Group: The Department’s employer research group
promotes research and education opportunities for employers who provide healthcare
benefits to their employees. Our goal is to partner with employers, employer coalitions,
and the health plans that administer employer-sponsored benefits in research activities
that will improve the quality, cost-effectiveness, and value of healthcare. Our areas of
interest and expertise include, but are not limited to:
o Providing education about value-based purchasing
o Measuring and managing employee productivity
o Evaluating health and disease management programs in employer settings
The Employer Research Group seeks to apply the Department’s knowledge and expertise
to answer employer related questions such as:
o How do I know if my organization is maximizing value in benefits purchasing?
o How do I evaluate and monitor the degree to which certain disease states and
expensive treatments impact the health and productivity of my employee
population?
o How can I obtain an independent evaluation of the effectiveness of the wellness
and disease management programs my organization currently pays for?
o How can I encourage employees, as healthcare consumers, to become more
engaged in health management and care-seeking decisions?
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Two additional research interest groups are in the formative stages. The first is a Public Health
Research Interest Group, focused on developing the Department’s agenda for community
partnerships and community-based research. The Department recently began conducting an
inventory of existing community relationships, as a starting point for this activity. The second
research interest group will be examining the impact of global climate change on health. The
group currently is examining the existing literature on the impact of climate on health and
disease, and will seek to contribute to the body of evidence through epidemiologic and statistical
approaches.

27

1. Funded Project List
The following table presents information on Department of Health Policy research grants that were
active at any point during the 2006-2007 academic year. The status column indicates whether the grant
remained open as of the end of the academic year.
Title and Brief
Description
College for the Advanced
Management of Health
Benefits – A training
program on value-based
purchasing of employee
health benefits

Investigators

Source of Support

Total Amount

N. Goldfarb,
D. Nash

$ 90,000
(annually)

Predictive Model
Evaluation Using the
Medicare Current
Beneficiary Survey
(MCBS)

N. Goldfarb,
V. Maio, J.
Diamond
(Family and
Community
Med), K.
Novielli
(Assoc Dean)
D. Nash, N.
Goldfarb, A.
Crawford, J.
Clarke
A. Crawford,
N. Goldfarb,
D. Nash
D. Nash, C.
Sciamanna

Administered in concert with
HealthCare21 and the National
Business Coalition on Health.
Funded by Johnson & Johnson
Health Care Systems,
AstraZeneca, Pfizer, Blue
Cross Blue Shield of
Tennessee, and Sanofi-Aventis,
and participant registration fees
ExcelleRx

$ 47,550

Open

Healthways

$350,000

Completed

Horizon Blue Cross Blue
Shield

$109,157

Open

Graduate Education
Foundation

$102,000

Completed

L. Pizzi, J.
Lofland

Ortho-McNeil Janssen

$95,256

Completed

N. Goldfarb,
D. Nash, J.
Lofland, S.
Silberstein
(Neurology)
V. Maio. C.
Hartmann, N.
Goldfarb, D.
Horn
(Infectious
Dis)
N. Goldfarb,
B. Goldberg
(Endocrin.)

Ortho-McNeil Janssen

$439,503

Open

MediMedia/Pfizer

$201,000

Completed

GSK

$ 98,410

Completed

Evaluation of Disease
Management Interventions

Evaluation of Patientoriented Interventions to
Improve Quality of Care
Evaluation of Online
Continuing Medical
Education for Physicians
Economic Analysis of
Productivity Data from the
Topamax Trial
Development of a National
Quality Measurement Set
for Migraine

Cost Identification Study
for Inpatient Candidal
Infections

Relationships between
Changes in Glycemic
Control and Changes in
Diabetes Pharmacotherapy
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Status as of
6/30/07
Open,
renewed
annually.
Will continue
in 2008.

Economic Impact of
Breakthrough Pain
Measurement of
Productivity Loss
Associated with
Overactive Bladder
Research Awards Program
for the IAQ Instrument
Evaluation of On-site
Pharmacy Access for
Community Health
Centers
Impact of Performance
Improvement Modules in a
Group Practice Plan
Impact of
GetWellNetwork on
Handwashing Behavior in
Inpatient Care
Physician Profiling and
Appropriateness of
Prescribing for the Elderly
in Italy
Policy Implications of
Non-adherence to
guidelines and
prescriptions
Evaluation of the Impact
of Soarian Workflow
Management on Inpatient
Operations
Economic Evaluation of a
Stress Management
Program
Evaluation of a WebBased Training Program
for Neurology Residents
Outcomes Evaluation of
the Charite Artificial Disc
Impact of the Charite
Artificial Disc on Indirect
Costs

Prevalence of and
Attitudes toward GERD in
Minority Populations
Colorectal Cancer
Screening Capacity and
Insurance Coverage in PA
Economic modeling and
patient identification
algorithms for candidemia

L. Pizzi

Cephalon

$198,621

Open

L. Pizzi, J.
Lofland

Watson

$119,983

Completed

L. Pizzi, N.
Goldfarb
V. Maio, L.
Pizzi,
N. Goldfarb

BMS

$100,000

Open

Health Federation of
Philadelphia

$ 20,000

N. Goldfarb,
A. Crawford,
D. Nash
D. Nash, R.
Jacoby

American Board of Internal
Medicine

$ 10,000

Open

GetWellNetwork

$ 70,000

Open

V. Maio

Azienda Italy

$ 74,351

Open

D. Nash

GSK

$ 61,550

Completed

N. Goldfarb,
A. Crawford,
D. Nash

Siemens

$ 60,000

Completed

N. Goldfarb

Johnson & Johnson

$100,000

Open

D. Nash, K.
Kash, A.
Skoufalos
N. Goldfarb

American Headache Society

$195,098

Open

Clinical Connexion

$148,854

Completed

T. Bunz, N.
Goldfarb, A.
Vaccaro
(OrthoSurg),
J. Harrop
(NeuroSurg)
E. Yuen, N.
Goldfarb

DePuy Spine

$ 25,000

Open

AstraZeneca

$109,372

Open

R. Myers
(Medicine),
M. Sarfaty
T. Bunz, N.
Goldfarb, V.
Maio

Pennsylvania Legislative
Budget Committee

$116,736

Completed

Medimedia/Pfizer

$113,398

Open
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Open

Qualitative study of key
opinion leader views on
specialty pharmacy
management
Development of an
economic model for
overactive bladder
Improving stakeholder
knowledge of
cardiometabolic risk
Improving hospital quality
for rural hospitals in
Pennsylvania
Literature review on costeffectiveness of diagnostic
radiologic procedures as
preventive screening tests
Development of
ambulatory care quality
measures
Economic Impact of
Pharmacotherapy for
Chronic Disease
Total

L. Pizzi

Berlex

$69,156

Open

L. Pizzi, T.
Bunz

Watson Pharmaceutical

$25,483

Open

N. Goldfarb,
D. Nash

Tricore Interactive/ SanofiAventis

$185,000

Open

D. Nash, N.
Goldfarb, A.
Skoufalos
N. Goldfarb,
R. Jacoby

Commonwealth of
Pennsylvania/IPCC

$400,000

Completed

GE Healthcare

$58,267

Open

D. Nash,
A. Crawford,
N. Goldfarb
T. Bunz, N.
Goldfarb, D.
Nash

West Virginia Medical
Institute/CMS

$97,568

Open

PhRMA

$62,542

Open

$3,953,855
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2. Publications
The Department’s mission to disseminate research findings and policy-relevant information to a
national audience is fostered through the publications that are managed and edited by the
Department, as well as the faculty’s seeking publication of its scholarly work in these and other
peer-reviewed publications.
The Department’s publication output includes four peer-reviewed journals: the American Journal
of Medical Quality (AJMQ), the official journal of the American College of Medical Quality;
Biotechnology Healthcare; Disease Management, the official journal of the Disease
Management Association of America; and Pharmacy and Therapeutics (P&T). David B. Nash,
MD, MBA is the editor-in-chief of all four journals. Three faculty members, Neil Goldfarb,
Albert Crawford, and Vittorio Maio serve as associate editors of the American Journal of
Medical Quality. The publication list below does not include the many editorials and columns
resulting from these efforts. Details on each journal follow:
American Journal of Medical Quality – As the national conversation regarding the
measurement and improvement of healthcare quality and patient safety evolves, it is clear that
AJMQ will continue to play a national leadership role. The Chair has completed three full years
as the editor-in-chief for the twenty-year-old peer-reviewed journal. In this role, he presides over
a prestigious ninety-five person editorial board, drawn from organizations across the United
States and overseas. AJMQ is closely affiliated with the University HealthSystem Consortium
(UHC) in Chicago, Illinois, and several senior UHC officials also serve as associate editors of
the journal. This affiliation provides the journal with access to important operationally-based
quality and safety projects from many UHC constituent members. AJMQ recently launched a
column devoted to the American Hospital Association-sponsored National Patient Safety
Fellowship Program, further enhancing AJMQ’s leadership role in this important arena.
Research Fellows in the Department also regularly contribute a peer-reviewed literature
assessment section to AJMQ.
As was noted earlier in this report, AJMQ received tremendous national press with regard to the
special supplement devoted to the Pennsylvania-based, hospital-acquired infection report,
significantly raising the journal’s impact factor. Another supplement, published in the spring,
was devoted to coordinating the management of complex co-morbid conditions. Finally, AJMQ
published three critically important annotated bibliographies emanating from the work of our
medical school research assistants. These annotated bibliographies focused on the following
topics: governance and leadership of the healthcare system; an update on the ACGME
competencies; and the first-ever annotated bibliography of the world’s literature focusing on the
quality of ambulatory care. These articles received major national attention and reprints were
distributed to thousands of persons across the country.
Biotechnology Healthcare – The Department continued to serve as the editorial home for
Biotechnology Healthcare, a controlled-circulation publication focused on the socioeconomic
and political issues in the burgeoning field of biotechnology, with an emphasis on the human
genome. It is distributed bimonthly and has a national circulation of 35,000. A seventymember editorial board was assembled by the Department and includes representative leaders
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from every sector within the biotechnology arena including, bioethics, law, the basic sciences,
public policy, and the pharmaceutical industry. This year editorials by the Chair focused on such
topics as public policy for personalized medicine, the future of biologically-based
telecommunications, and highlights from a regional biotechnology corporate incubator. Among
the feature articles this year was an interview with Steven McKenzie, MD, PhD, Jefferson’s Vice
President of Research.
Disease Management – The Department continued its exclusive editorial directorship of Disease
Management, the only peer-reviewed journal in the field of chronic disease management. The
journal continues to be recognized through acceptance in Medline and Index Medicus. The
editorial board consists of more than sixty-five persons across the United States in such fields as
managed care, the pharmaceutical industry, the disease management industry, epidemiology, and
public health. Disease Management is published bimonthly and reaches a paid national
circulation in excess of 1,300. The Chair is also a member of the Board of Directors of the
Disease Management Association of America (DMAA), the leading national organization
concerned with the public policy issues in disease management, which has evolved to be the gold
standard for research in this burgeoning field. The journal’s editorial board held its annual inperson meeting during the DM Colloquium (a symposium hosted by the Department) in May
2007. Periodically, supplements to Disease Management are published under the editorial
guidance of the Department. This year, the following supplement was published: Preventive
Medicine: A “Cure” for the Healthcare Crisis. Clarke JL and Meiris DC. Disease Management.
2006, Vol. 9, (Suppl) S1-S16.
Pharmacy & Therapeutics (P & T) – The Department completed its eighth full year as editor
and continuing education provider for P & T, a nationally recognized peer-reviewed journal
concerned with all aspects of pharmaceutical use and care. P & T has a national monthly
circulation in excess of 60,000. The editorial board of the journal is continuously updated,
bringing in persons with expertise in pharmacoeconomics research and disease management, in
addition to those with a general pharmaceutical industry background. The Chair continues to
write a monthly editorial for P & T. These editorials are often reprinted elsewhere and garner
email response on a regular basis. Topics this past year included such areas as the British
National Health Service NICE program, the pay-for-performance program under Medicare, and
consumer engagement.

Other Publications
Health Policy Newsletter – The Jefferson Health Policy Newsletter is now in its sixteenth year
of publication under the direction of the Department of Health Policy and is about to celebrate its
20th anniversary. The Newsletter serves as an important part of the TJU commitment to
disseminate information on health policy locally, regionally and nationally. The Newsletter is
sent out on a complimentary basis to all physicians and senior administrators throughout the
JHS. In addition, the Newsletter has more than 26,000 subscribers worldwide and has been
distributed at scores of national medical meetings. Editorials from the Newsletter are often
reprinted in other publications. Letters to the editor demonstrate widespread readership of the
Newsletter, especially among members of the national health policy community. Once again, the
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Department would gratefully like to acknowledge the support of Max Koppel, MD, MBA, MPH
(JMC ’57) who has generously continued to provide additional resources to help defray the cost
of the Newsletter’s publication. The editorial board of the Health Policy Newsletter continues to
evolve, with some individuals serving for the past fifteen years and other on-campus leaders
being added on a regular basis. The Newsletter editorial board meets quarterly and solicits
contributions from across the campus and the region. The lead editorials in the Health Policy
Newsletter, written largely by the Chair, have covered such topics in this past year as Medicare’s
Roadmap, professionalism and patient safety, and activating patient involvement.
Value-Based Purchasing – Housed on the Jefferson Digital Commons, Value-Based Purchasing
is a quarterly newsletter produced through the Department’s work with the College for Advanced
Management of Health Benefits. The newsletter provides information for employers to support
their benefits purchasing behaviors based on issues of value and quality, rather than solely on
cost.
Weekly Policy Newsletters – The Department produces three weekly newsletters: Pharmabites,
a summary of the week’s news in pharmaceutical development and evaluation; the HIT report,
covering health information technology developments; and Quality Spotlight, summarizing news
from the quality and safety improvement movements. Content for the newsletters is generated
by Department staff, through their scanning of news services, journals, the press, and other
media. The newsletters are distributed to a growing audience, including Department members,
Jefferson faculty and administrators who collaborate with the Department, the Senior Scholar
network, and other Department contacts who have requested being added to the mailing list.
Texts – Two books, edited by members of the Department faculty in the previous year, continue
to do well. Economic Evaluation in US Healthcare: Principles and Applications (by Pizzi and
Lofland) and The Quality Solution: The Stakeholders Guide to Improving Healthcare (by Nash
and Goldfarb) are used as core texts in the growing TJU MPH Program on our campus.
As noted earlier, during the past year the Department published the multi-authored edited text
entitled Practicing Medicine in the 21st Century with the American College of Physician
Executives in Tampa, Florida. This multi-authored text was designed as a primer to prepare new
physicians for practicing in a changing healthcare environment. It was highlighted during the
November 2006 dean’s conference entitled “Medicine 2020,” where all attendees received a
complimentary copy. A copy of the book was also provided to the entire Jefferson Medical
College Class of 2011 during their student orientation. This book continues to break all sales
records of the American College of Physician Executives, as it is in use in schools of medicine,
public health, management and law across the country. Finally, various pharmaceutical
companies have made bulk purchases of this book in order to disseminate it more widely to
residency training programs across the country. Aspects of this dissemination plan were covered
earlier in this report.
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3. List of Presentations
1. Brixner D, Maio V. Analysis of Prescribing Patterns of Antihypertensive Agents Before
and After Publication of the Antihypertensive and Lipid-Lowering Treatment to Prevent
Heart Attack Trial (ALLHAT). 9th Annual European Congress of the International
Society Pharmacoeconomics and Outcomes Research, 28-31 October 2006, Copenhagen,
Denmark.
2. Brixner D, Ghate S, McAdam Marx C, Maio V. Analysis of Prescribing Patterns of
Antihypertensive Agents Before and After Publication of the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT). 1th Latin America
Conference of the International Society Pharmacoeconomics and Outcomes Research, 911 September 2007, Cartagena, Colombia
3. Gagne JJ, Leas BF, Goldfarb NI, Hopkins MM, Lofland JH, Rupnow MFT, Nash DB,
Silberstein S. Developing a Migraine Quality of Care Measurement Set. Poster
presented at American Academy of Neurology Annual Meeting, 2007.
4. Gagne JJ, Maio V, Rabinowitz C, Louis DZ. Prevalence of Clinically Important Potential
Drug-Drug Interactions in Regione Emilia Romagna, Italy. 12th Annual Meeting of the
International Society Pharmacoeconomics and Outcomes Research, May 21, 2007,
Washington, DC
5. Gagne JJ, Breitbart RE, Maio V, Horn DL, Hartmann CW, Swanson R, Goldfarb NI.
Costs Associated with Candidemia in a Hospital Setting. 46th Annual International
Conference on Antimicrobial Agents and Chemotherapy, 27-30 September 2006, San
Francisco, CA
6. Goldfarb N and Leas B. Outpatient Quality Improvement in Faculty Practice Plans:
Update on a UHC Survey. Presented at University HealthSystem Consortium
Ambulatory Care and Group Practice Joint Council Meeting, 2007.
7. Goldfarb N, Crawford AG, Koran J, Chapman H, Nash DB. Physician Engagement to
Promote Ambulatory Quality and Safety among the Jefferson University Physicians.
Poster presentation at the University HealthSystem Consortium 2006 Quality and Safety
Fall Forum. Baltimore, MD, October 2006.
8. Grabo DJ, DiMuzio PJ, Kairys JC, McIlhenny SE, Crawford AG, Yeo CJ. Have
Endovascular Procedures Negatively Impacted General Surgery Training?" Presented at
the American Surgery Association Meeting, Colorado Springs, CO, April 26-28, 2007.
9. Hayes E, Almario C, Pizzi LT, Kraft W, and Baxter J. Low Molecular Weight Heparin,
the Most Cost Effective Treatment of Venous Thromboembolism. Poster presentation at
the Society for Maternal Fetal Medicine (SMFM) 27th Annual Conference, San Francisco
California, February 2007.
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10. Hayes E, L, Freehill N, Pizzi LT, Baxter J. Nifedipine is the Most Cost Effective
Tocolytic. Poster presentation at the Society for Maternal Fetal Medicine (SMFM) 27th
Annual Conference, San Francisco California, February 2007.
11. Holtzer B, Johantgen M, Geiger-Brown J, and Crawford A. Factors Influencing Care
Coordination for CSHCN. Presented at the AcademyHealth Child Health Services
Research Meeting, Seattle, WA, June 24, 2006.
12. Kash KM. Consequence-Based Learning (CBL): A Preliminary Analysis of Outcomes.
Presented at the 49th Annual Meeting of the American Headache Society, Chicago, IL.
June 09, 2007.
13. Kash KM. Jefferson School of Nursing ACE Day Cancer Survivor Panel Participant,
Philadelphia, PA. August 14, 2006
14. Kash KM. Psychosocial Oncology: Supportive Care for the Cancer Patient. Medical
Staff Education Days at Chambersburg Hospital, Chambersburg, PA. September 15, 2006
15. Kash KM. The Ethical Implications of Genetic Testing for BRCA1 and BRCA2.
IMPACT and AIDIT Meeting, Szczecin, Poland. November 29, 2006
16. Kash KM. New Directions in the Psychosocial Aspects of Genetic Testing for
Cancer. Psychosocial Aspects of Genetic Testing for Hereditary Cancer 9th
Meeting, Manchester, UK. May 22, 2007
17. Leas BF, Gagne JJ, Goldfarb NI, Rupnow MFT, Lofland MH, Hopkins MM, Nash DB,
Silberstein S. Assessing and Improving Migraine Care Quality: Development
of a Model Health Plan Quality of Care Measurement Set. Poster presented at
American Headache Society Annual Scientific Meeting, 2007.
18. Leas BF, Gagne JJ, Goldfarb NI, Rupnow MFT, Lofland JH, Hopkins MM, Nash DB,
Silberstein S. Developing a Migraine Quality of Care Measurement Set. Poster
presented at International Society of Pharmacoeconomics and Outcomes Research
Annual Meeting, 2007.
19. Lee SP, Bunz T, Gagne JJ, Maio V, Goldfarb NI. Determinants of Total Hospital Costs
Among Inpatients with Candidemia. 12th Annual Meeting of the International Society
Pharmacoeconomics and Outcomes Research, May 22, 2007, Washington, DC
20. Maio V, Yuen EJ, Smith KD, Louis DZ. Prescribing patterns following publication of the
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
(ALLHAT) in Regione Emilia Romagna, Italy. AcademyHealth 2006 Annual Research
Meeting, June 25, 2006, Seattle, WA.
21. Pizzi LT, McIlwain M, Dahl NV. Safety of Transdermal Oxybutynin in the Treatment of
Overactive Bladder among Patients Using Other Transdermal Medications: Results of the
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MATRIX Study. Accepted for poster presentation at the 108th Annual Meeting of the
American Society for Clinical Pharmacology and Therapeutics (ASCPT). Anaheim
California, March 2007.
22. Pizzi LT, Gagne JJ, Lofland JH, Rupnow M, Smith KD, and Poston S. Effect of
Topiramate Migraine Prophylaxis on Workplace Productivity: Results from Two U.S.
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trials. Poster presentation
at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles
California, June, 2006.
23. Sand PK, Kelleher C, Pizzi LT, and Dahl NV. Effect of Treatment For Overactive
Bladder on Work Productivity: Results from the MATRIX Study. Poster presentation at
the International Urogynecological Association (IUGA) 31st Annual Meeting, Athens
Greece, September 2006.
24. Sarfaty M, Shibao F. Addressing disparities in colorectal cancer. American Public
Health Association 134th Annual Meeting. Boston, November 3-7, 2006.
25. Sarfaty M, Myers R. HEDIS Measures and Changes in Screening Policies of
Pennsylvania Insurers. American Public Health Association Annual Meeting. Nov. 5.
Washington D.C.
26. Sciamanna, CN, Adams SY, Breitbart RE, Crawford AG, Thier SL, Rimal RM, Lee
JS, Janneck L. Computer-tailored Messages in the Care of Type2 Diabetes. Poster
presented at the Society of General Internal Medicine Annual Meeting: The Puzzle of
Quality: Clinical, Educational, and Research Solutions, Toronto, April 25-28, 2007.
27. Short J, Talati A, Maio V, Pizzi L, Lagermasini C, Goldfarb NI. Evaluation of the Impact
of the Philadelphia Community Pharmacy Network Program. American Pharmacists
Association 2007 Annual Meeting, March 18, 2007, Atlanta, GA
28. Yuen EJ. Meditation and Healthy Aging. Complementary and Alternative Medicine
for Elders. Eastern Pennsylvania Geriatrics Society, March 22, 2007, Conshohocken,
PA.
29. Yuen EJ, Louis DZ, Cisbani L, Rabinowitz C, Maio V, Marangolo M. Using
administrative data to assess patterns and quality of cancer care. Accepted at the 23rd
Patient Classification System International Conference, November 2007, Venice, Italy.
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C. Patient Care
The Department of Health Policy does not have a clinical practice base. Dr. Nash is the only
physician in the Department who currently sees patients, through ambulatory patient care in the
Division of General Internal Medicine and participating in the inpatient attending
physician/hospital service attending schedule.
The Department’s participation in patient care activities is most directly achieved through our
leadership role in performance measurement and improvement activities for the outpatient
practices of Jefferson University Physicians. Dr. Nash chairs the JUP Clinical Care
Subcommittee, and Neil Goldfarb, Vice Chair for Research, serves as JUP’s Director of
Ambulatory Care Performance Improvement. Additional Departmental staff working on JUP
initiatives include:
o Bettina Berman, RN, Project Director for Quality Improvement (funded 100% by JUP)
o Al Crawford, PhD, MBA, MSIS, Senior Analyst (funded 50% by JUP)
o Erin Whitesell, MPH, Junior Analyst (funded 50% by JUP)
o Richard Jacoby, MD, Physician Advisor (provided to JUP, in-kind, by DHP)
o Valerie Pracilio, Project Coordinator for Quality Improvement (provided to JUP, in-kind,
by DHP)
Departmental outcomes research fellows also participate in JUP Departmental initiatives.
Among the key accomplishments of this team, in collaboration with the JUP Clinical Care
Subcommittee and JUP Departments over the past year are:
• Conducting performance measurement initiatives in almost all JUP Departments, on
measures selected by the departments based on clinical relevance and interest in assessing
and improving quality
• Launching a JUP-wide smoking cessation initiative, in which all departments will
incorporate an assessment of smoking history, and counseling and referral for current
smokers, into their ambulatory care patient assessments and clinical documentation
• Helping departments to track development of the CMS Physician Quality Reporting
Initiative (PQRI) – a Medicare pay-for-performance initiative – and to select measures to
report, to implement measurement, and to track progress via periodic data analytic reports
• Helping JUP administration to develop Independence Blue Cross pay-for-performance
program parameters, monitor JUP performance on these measures, and plan performance
improvement initiatives which address these measures
• Participating in planning sessions for implementation of an electronic health record in the
JUP outpatient practices, and developing parameters for record templates, to ensure that
quality data needed for pay-for-performance and public reporting programs are captured
• Pilot testing the Physician Practice Patient Safety Assessment (PPPSA) in the General
Internal Medicine practice, and developing a plan for implementation in all other JUP
practices, in order to systematically measure and address opportunities for improving
patient safety in the outpatient setting
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D. Affiliations
The Department maintains a wide range of affiliations, within the Jefferson community and in
the broader local, regional and national healthcare system. Aspects of this work were reviewed
in the General Overview section.
Internal affiliations that bolster the mission of the Department are many and varied. The
Department serves as a data, analytic and education resource, and provides value-added
healthcare consulting to Jefferson Medical College, Thomas Jefferson University Hospital
(TJUH), and—to some extent—the Jefferson Health System (JHS). The Chair serves as a
founding member of the JHS Quality Council, chaired by Stanton N. Smullens, MD, the
system’s Chief Medical Officer. Other aspects of the consulting mission are expressed through
the Chair’s service on various committees. These include membership on the hospital’s
Pharmacy and Therapeutics Committee (a position he has held for eighteen years) and chairing
the Quality Medication Subcommittee of the P & T Committee. The Chair also serves on the
TJUH Clinical Performance Improvement Committee and was appointed to the TJUH PEACE
Committee (Pharmacoeconomics and Cost Effectiveness). These committees combine to
represent an important operational component of the Hospital and University’s commitment to
measuring and improving the quality and safety of medical care. The critical contribution to the
JUP Clinical Care Committee is covered elsewhere in this report.
Other internal affiliations include the Chair’s service on the very important JMC Committee on
Appointments and Promotions. This has been an integral part of the Chair’s leadership
responsibilities for JMC, especially as many new Health Policy Departmental faculty proceed
through the appointment and promotion process. In addition, the Chair recently was named an
associate member of the Kimmel Cancer Center here on campus. This is an important affiliation,
which will continue to build our interdisciplinary research agenda. Similarly, the Chair served
on the Search Committee for the inaugural Dean of the Jefferson School of Pharmacy. In
addition, after successfully recruiting the top candidate, the Chair has been asked to serve on the
School of Pharmacy Steering Committee and to help select its future national members. The
Vice Chair for Education has been appointed to the JMC CME Committee, as the Department is
one of the top CME providers in the medical school. Membership on this committee will
continue to be very important to the day-to-day activities of the education division. Finally,
Mona Sarfaty, MD, a Department faculty member who oversees MPH program curriculum
issues, has been appointed to the JMC Curriculum Committee, as this committee will deal with
future issues regarding the integration of our growing MPH Program with the existing JMC
infrastructure.
The Department’s Senior Scholars Program, an important bridge between internal and external
affiliations, continues to grow. This program recognizes individuals who make a commitment to
the Department to participate, in a modest way, in our ongoing research and educational
activities. The Senior Scholars now number over 250 persons who represent local, regional, and
national leaders in industry and academia, all within commuting distance of the Department.
The Senior Scholars receive regular updates via email and the newsletter on the activities of the
Department and serve as mentors to the Fellows and junior faculty.
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At the state level, the Department has an ongoing research affiliation with the Pennsylvania
Healthcare Cost Containment Council (PHC4). Dr. Nash also chairs the PHC4 Technical
Advisory Group (TAG), a role he has had for the past twelve years. The PHC4 has continued to
publish statewide outcomes reports on coronary artery bypass graft surgery, the quality of care in
HMOs throughout Pennsylvania and this year, the first ever, statewide, hospital-specific hospitalacquired infection report. This report was described in detail in the introductory section of the
Annual Report. PHC4 and the TAG regularly are featured in newspaper stories in the
Philadelphia Inquirer, Philadelphia Business Journal and many national press outlets.
The Chair maintained a large number of consultancies with firms in the private sector, especially
those concerned with e-health and e-commerce. For example, the DHP completed the seventh
year of a strategic planning initiative with GE Medical Systems. The Chair also leads the GE
Medical Quality Improvement Consortium (MQIC), a national group of 12,000 physician
ambulatory electronic medical record users. Once again, this is how the Department links its
external consulting work, research agenda and educational dissemination planning.
On a national policy level, the Department has increased its participation in the debate
surrounding the quality and safety of medical care, along with improving access. This was
achieved, in part, by the Chair’s personal involvement with numerous professional societies in
the following capacities:
•

Continued 13th year as Chairman of the IMS (Plymouth Meeting, Pennsylvania)
sponsored national disease therapeutic index, NDTI. This is an internationally regarded
physician-specific pharmacy tracking and research program.

•

Membership on the National Quality Forum (NQF) and the Council on Research and
Quality Improvement. The Chair was also appointed to direct the NQF Technical
Advisory Panel (TAP) on guidelines for ambulatory pharmacy management for a second
year.

•

Continued membership for a decade on the Board of Trustees of Catholic Healthcare
Partners (CHP), the 10th largest nonprofit integrated delivery system in the country,
headquartered in Cincinnati, Ohio. The Chair continued to lead the CHP Board
Committee on Quality and Safety. He is regularly invited to address quality-related
issues for many of the constituent institutions of the CHP and served on the Steering
Committee for the annual CHP Governance and Leadership Retreat.

•

Continued membership on the Board of Directors of the Disease Management
Association of America (DMAA), the major national group representing the disease
management industry in Washington, DC. The Chair is a member of this board in
perpetuity as he is the editor of Disease Management, the official journal of the DMAA.

•

The Chair continued his role on the Medical Leadership Council (MLC) of the University
Health System Consortium (UCH) and the MLC Executive Committee – the key group of
physicians who help to set the quality improvement strategy for the UHC. In addition,
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the Chair is on the Ambulatory Quality Steering Committee of the UHC. This year, a
member of the Department (who is also a member of the JUP Clinical Care Committee)
served as one of the inaugural UHC Quality Fellows, linking the quality agenda of the
Department and of JUP with cutting-edge national training programs in this important
arena. Also, the American Journal of Medical Quality features a regular contribution by
the National Patient Safety Fellowship Program sponsored by the American Hospital
Association.
•

The Chair was appointed this past academic year to the Highmark Blue Cross/Blue
Shield Corporate Board and was asked to serve on the board’s Quality Improvement
Committee. He will Chair this committee starting in the spring of 2008.

•

The Chair continues to serve on the CIGNA National Physician’s Advisory Committee
(PAC). The PAC is the only national committee whereby CIGNA receives feedback
from practicing physicians in their network across the country.

•

The Chair was appointed as a judge for the national URAC-sponsored Best Practices in
Consumer Empowerment and Protection Conference. In this capacity, he served with
others to review hundreds of submissions from across the country that promote healthcare
quality via accreditation and certification programs.

•

The Chair was appointed to the regionally-based Purchasers Alliance for Transforming
Healthcare (PATH) Advisory Committee. This represents one of the very few
regionally-based business coalition efforts to link the purchasers and providers of
healthcare.

Through membership and activity sponsored by such groups as the NDTI, NQF, CHP, DMAA,
and the UHC, the Department is at the center of major national programs involved in measuring
and improving the quality and safety of healthcare. The local, regional and national activities of
the Chair and members of the Department garnered a great deal of press attention this past year.
More than three dozen stories regarding the work of the Department were in the national press,
including two feature cover stories in the July 23-30, 2007 issue of U.S. News & World Report
and the July/August 2007 issue of Trustee magazine. Reprints of these cover stories are
available from the Department.
The Chair continued to ably represent the work of the Department and its research and education
mission via his invited presentations across the nation. In this past academic year, the Chair
delivered more than thirty formal presentations to organizations outside of Pennsylvania and
seven presentations to organizations within the region. He also received the prestigious Elliot
Stone Outcomes Research Award from the National Association of Health Data Organizations
(NAHDO) during their annual meeting in December 2006, in Washington, DC.
In the private sector, the Chair continued his board membership and consultative activities with a
broad range of organizations. As mentioned earlier, the Chair is a member of the Board of
Directors of two publicly held companies. He serves on the Board of I-Trax Corporation
(AMEX:DMX), a disease management firm, where he also chairs the Board Nominating
Committee. He also continues to serve on the Board for Informedix (OTCBB:IFMX) in
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Rockville, Maryland. He was also named to the National Advisory Board of the TLC
Corporation in Chicago, Illinois. This is a privately held company recently purchased by
Revolution Health that creates patient-specific websites during hospitalization to facilitate
communication between patients and their relatives. The Chair is also on the National Scientific
Advisory Board of the Nanosphere Corporation (headquartered in Chicago, Illinois). This
privately held company is committed to creating path-breaking screening tests for cancer and
other serious illnesses utilizing office-based nanotechnology screening tools. These multiple
private sector initiatives provide additional sources of external financial support for the
Department, as well as relevant databases for the research mission. All relevant conflict of
interest forms and confidentiality statements are on file with the Office of the University
Council.
Implementing operational improvements in quality, safety, access and cost-effective use of
resources is a major challenge. As previously noted, the Chair continued to serve as a member
of the Board of Trustees (and on the Quality and Safety Committee) of Catholic Healthcare
Partners (CHP), the nation’s 10th largest integrated delivery system. This past year, CHP
published a major national strategic document outlining its commitment to quality and safety
improvement. CHP’s central headquarters staff in Cincinnati, Ohio continues to grow, and their
educational programming, data analysis and leadership institute are a major credit to the
organization’s quality agenda. Through their important work, involving nearly 35 hospitals with
40,000 employees, CHP can have a major impact on the national agenda for quality, safety,
access and public accountability.
As noted above, the Chair also serves on the corporate board of the Highmark Blue Cross/Blue
Shield Association headquartered in Pittsburgh, Pennsylvania. Highmark is the largest Blue
Cross Plan in the state and has publicly announced its intent to merge with Independence Blue
Cross in Philadelphia, creating a consolidated Blue Cross Plan for Pennsylvania. The Chair also
serves on the Quality Improvement Committee of Highmark and recently was asked to lead this
committee in the next calendar year. At the national and state level, these responsibilities give
the Chair and the Department an opportunity to operationalize the concepts behind improving the
quality, safety and access to medical care.
E. Interdepartmental Programs
As presented in the information on Education and Research activities in the sections above, the
Department has formed many productive working relationships with other JMC and University
Departments. In brief, these include:
•

Leadership of the performance measurement and improvement activities for Jefferson
University Physicians, through JUP’s Clinical Care Subcommittee

•

A project seeking to develop a national migraine quality measurement set, in
collaboration with the Department of Neurology’s Headache Center.
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•

Assessment of incidence of breakthrough pain, including patients recruited from
Jefferson’s Pain Center, Headache Center, Department of Neurology, Sickle Cell Clinic,
and Division of Rheumatology.

•

Economic evaluation of candidemia in the inpatient setting, in collaboration with the
Division of Infectious Diseases.

•

Economic evaluation of the Charite artificial disc, in collaboration with the Departments
of Neurosurgery and Orthopedic Surgery.

•

Analysis of the Medicare Current Beneficiary Survey data to identify the impact of
appropriate pharmacotherapy on patient outcomes, in collaboration with Dr. Novielli in
the Dean’s Office, and the Department of Family and Community Medicine

•

Statewide assessment of colorectal cancer screening capacity and activity, in
collaboration with the Department of Medical Oncology

•

Co-direction of the MPH program with the Department of Family and Community
Medicine.

•

Publication of the quarterly Health Policy Newsletter, whose editorial board consists of
members from the Dean’s office; the Jefferson Foundation; the College of Health
Professions; the Department of Medicine; the Department of Family and Community
Medicine; the Center for Research in Medical Education; and also includes
representatives from across the Jefferson Health System (Einstein, Frankford, Main Line
Health, and Christiana).

•

Clinical and hospital orientation training for pharmaceutical representatives, in
collaboration with the Hospital Pharmacy.

•

Clinical training in diabetes diagnosis and management, in collaboration with the
Department of Family and Community Medicine, Department of Pathology and
Department of Endocrinology.

•

Clinical training regarding asthma and allergic rhinitis, in collaboration with the
Department of Family and Community Medicine, Department of Pulmonology,
Department of Pathology and Department of Pediatrics.

•

Clinical training regarding migraine, in collaboration with the Department of Family
and Community Medicine, the Headache Center, Department of Neurology, Department
of Psychiatry, Department of Obstetrics and Gynecology, and Emergency Medicine.

•

Clinical training in cardiovascular disease, in collaboration with the Department of
Cardiology, and the Department of Family and Community Medicine.
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F. Faculty
The Department has continued to build a strong, well-rounded and diverse faculty. Disciplines
represented on the Department’s faculty include: public health, medicine, nursing, social work,
sociology, pharmacy science, pharmacoeconomics and pharmacoepidemiology, education, health
care management, philosophy, psychology, business administration, and statistics. The
Department’s faculty are well-poised to lend their collective interdisciplinary strengths to
Jefferson’s strategic plan implementation. As discussed above, Department faculty lead the
Master’s of Public Health Program, teach program courses, and mentor enrolled students. The
Department also has been actively engaged in curriculum planning for the new School of
Pharmacy. Laura Pizzi, PharmD, MPH, Division Director for Pharmacoeconomics and
Outcomes Research, participates on the core planning committee for the School, and Department
faculty have been identified to teach courses including Introduction to Health Systems, Statistics,
Pharmacoepidemiology and Pharmacoeconomics, and Complimentary and Alternative Medicine.

G. Departmental Administration
The administrative team for the Department includes a Department Administrator, a Grants
Manager, an Office Manager, and two Administrative Assistants. This staff serves the
administrative needs of the entire Department, including the Chair and faculty, in support of our
research and educational goals. It manages the portfolio of over 40 grants at any one time, and
ensures that all fiscal and compliance issues are handled appropriately.
The Department Chair meets monthly with the Vice Chairs of Research and Education, and the
Department Administrator, Office Manager, and Grants Administrator, to review financial
reports and discuss administrative issues. The Department Chair, the Vice Chairs of Research
and Education, and the Department Administrator compose the Department’s “Steering
Committee” and meet weekly to discuss strategy, staffing, new business development, and
project management issues.
During the last year, the administrative team has assumed additional responsibilities related to
the Schweitzer fellowship program and the Department’s further involvement with the MPH
program. As we begin the ’07 -’08 academic year, due to shifting of personnel within the
Department, we look forward to the hiring of a new Grants Administrator and a new
Administrative Assistant.
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H. Strategic Priorities
The Department of Health Policy is proud of its many achievements over the past year, as
documented in this admittedly lengthy report. These accomplishments are the result of hard
work and high-quality work from our faculty and staff. We actively promote continuous workbased learning and encourage staff members to pursue advanced degrees; currently, 10 of our
research and education staff members are enrolled in advanced degree programs or taking
graduate-level courses. We will continue to promote continuing education within our
Department, to parallel our efforts to educate other stakeholders across the health care system.
As we continue to build the core faculty, we will seek to further develop disciplinary and
demographic diversity. One priority for the coming year is to expand the doctoral level
pharmacist faculty within the Department, both to address the Department’s continuing work in
pharmaceutical evaluation, and to further support the School of Pharmacy’s teaching and
mentorship needs. We also will continue to develop faculty with public health degrees and/or
population health management experience in order to further support the Jefferson strategic plan.
One challenge to the Department has been the lack of core support for faculty development;
continued growth has occurred solely through deployment of external sources of support.
Within the Jefferson community, we will continue to seek to develop research and education
relationships with other departments and units of the University. Our inter-departmental
collaborations in pharmacoeconomics and outcomes research, health services research, and
quality improvement have directly linked our Department with the University’s strategic priority
areas: cancer, cardiac care, neuroscience, infectious disease, and, of course, population and
public health. Our faculty will continue to network with clinical faculty on the Jefferson
campus, to explore common interests and develop additional collaborations.
In the broader local community we serve, we will continue to seek partnerships to improve the
population’s health. We will continue to make evaluation consulting services available to
community agencies and seek grant funding to support research and education collaborations.
Expansion of the Masters of Public Health program and the Delaware Valley Schweitzer Fellows
Program also will help foster relationships while better serving the population’s needs.
On the state and national levels, we will focus this year on developing strategies to expand our
Department’s interaction with and influence on policy-makers, including legislators. A key
component of this activity will be developing effective education and dissemination strategies.
In addition to the current portfolio of publications, we will consider how best to reach the
legislative audience, be it through issue briefs, launching a Departmental blog, or other
communication strategies.
Another ongoing priority for the Department is to seek diversity in funding streams for research
and education programs. Nearly 50% of the Department’s funded work is supported by the
pharmaceutical and biotechnology industries. While we recognize the importance of this
funding source, and are proud of the contributions we have made to scientific knowledge with
industry support, we continue to believe that we have not yet fully leveraged our abilities to
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obtain foundation and government grant support. A priority for the coming year is to more fully
identify foundations that support research and education programs within the scope of our
expertise. We will continue to conduct Internet research and consult with Institutional
Advancement to develop grant strategies to help achieve this strategic goal.
Lack of adequate infrastructure, particularly office space, is a critical issue which we will need to
address in the coming year. All of the Department’s current space allocation is being fully
utilized, to the point that half of the faculty are office-sharing. Expansion of faculty, support
staff, and programs cannot take place unless additional space options are identified and utilized.
As was mentioned earlier in this report, we are planning to expand our educational programming
in the form of specialized advanced education programs in the areas of quality improvement,
patient safety, and wellness and prevention. We believe this type of offering can provide
practical, ongoing professional development for physicians and other healthcare professionals,
help to diversify our revenue streams, and support the future development of the University’s
population and public health program.
Finally, the Department seeks to capitalize on its intellectual resources, experience and expertise,
and national network of Senior Scholars and other colleagues, to help the University achieve the
strategic priorities related to population health and health policy. To meet the challenge of
transforming healthcare in the 21st century, we stand ready to partner with the University in
fulfilling this vital part of its mission.
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49

Jefferson Medical College, Department of Health Policy, Table of Organization

(October, 2007)

David B. Nash, MD, MBA
Department Chair
David Glatter, MBA
Department Administrator

Maxine Rosen
Admin Assistant

Jean Davis

Admin Assistant

Elizabeth DeBonis
Office Manager

Chanika Townsend
Grants Manager

Neil I. Goldfarb
Vice Chair for Research

Laura Pizzi, PharmD, MPH
Division Director,
Pharmacoeconomics and Outcomes
Research

Alexandria Skoufalos, EdD
Vice Chair for Education

JoAnne Reifsnyder, RN, PhD
Division Director,
Health Policy and Health
Services Research

Rob Simmons, DrPH
Division Director, Public Health
Education and Research

Vittorio Maio, PharmD, MS, MSPH
Fellowship Director

See attached tables for Research and Education Program tables of organization
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Jefferson Medical College, Department of Health Policy, Research Program, Table of Organization
Neil Goldfarb
Vice Chair for Research
Research Assistant Professor

Quality of Care Research

Al Crawford, PhD, MBA, MSIS
Assistant Professor

Public Health Education
and Research

Health Policy and Health
Services Research
JoAnne Reifsnyder, RN, PhD
Division Director

Rob Simmons, DrPH, MPH
Division Director

Bettina Berman, RN
Project Director for Quality
Improvement

Lisa Chosed
MPH Program Coordinator

Thomas Bunz, PharmD
Research Instructor

Associate Professor
Vittorio Maio, PharmD, MS, MSPH

Mona Sarfaty, MD
Research Assistant Professor

Brian Leas, MA
Project Manager

Richard Jacoby, MD
Project Director
Nicole Cobb, MAOM
Erin Whitesell, MPH
Research Analyst

Laura Pizzi, PharmD, MPH
Division Director

Elaine Yuen, PhD
Research Associate Professor
Kathryn Kash, RN, MPhil, PhD
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Project Manager for Quality
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Joseph Yaskin
Project Manager

Project Manager
Coordinator, Schweitzer
Fellowship

Richard Toner
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Research Assistant Professor
Fellowship Director

Deborah Liao, PharmD
Paresh Chaudhari, PharmD, MPH
Outcomes Research Fellows
Diane Richardson, MS, PhD
Project Director

Varinder Singh, MS
Research Analyst

Jefferson Medical College, Department of Health Policy, Education Program, Table of Organization

Alexandria Skoufalos, EdD
Vice Chair for Education

Vacant
Director, Special Projects

Megan Hartman, MS
Project Director

Melissa Horowitz
Project Director

Jeannine Kinney
Project Manager

Deborah Meiris
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Darlene Sheaff
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JMC Department of Health Policy
Last Name

First Name

Senior Scholars
Degree

Title

10/30/07
Company

Allen

Harris

PhD

Principal

Harris Allen Group, LLC

Ammons

Linda

Esquire

Dean

Amstutz

Barbara

Executive Director

Widener University School of
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Vital Issues in Medicine

August
Anders
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Managing Director
JD, CPA, CHBC

Gilbert Tweed Associates, Inc.
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David

MD

Founder & CEO
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Evelyn
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Michael

MD, MBA, FACP
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Baum

J. Robert

PhD

Chairman, Highmark, Inc. / Associate
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Smith School of Business,
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Baumel

Mark

MD

Berger

Marc

MD
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Management/ Exec. Dir. US Human Health

Merck & Co., Inc.
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Eric

DO, MS

VP and Medical Director

AMERIGROUP New Jersey, Inc.

Bocuzzi

Stephen

Boland

James

PhD, MBA, FAHA
MD, MPH, FACS

Brown

Steven

MD

Burrus

W. Clint

Cacchione

Joseph

MD, FACC

Casale

Paul

MD, FACC

Casey

Donald

MD, MPH, MBA, FACP

West Virginia
University/Charleston Area
Medical Center
Med. Dir., Contracting & Provider Networks

Independence Blue Cross

Executive Vice President, Mgd. Markets &
Trade Dept.

King Pharmaceuticals, Inc.

Executive Vice President

Saint Vincent Health Center
The Heart Group

VP of Quality & Chief Medical Officer
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Atlantic Health

Last Name

First Name

Degree

Title

Company

Cohen

Richard

PhD, FACHE

President and CEO

Philadelphia Health
Management Corporation

Cohen

Hedy

RN, BSN, MS

Vice President

Institute for Safe Medication
Practices

Connors

Barbara

DO, MPH

Medical Officer, CMS Region III

Center for Medicare & Medicaid
Services

Cross

James

MD

National Medical Director

Aetna, Inc.

Cuerdon

Timothy

PhD

Health Systems Specialist

Office of Quality and
Performance

Cusack
Cutler

Susan
J. J.

RN, MSN, MBA, CHE

d'Arville

Carolyn

Davis

Diana

Denman
DeSanto

Jeffrey
Tom

De Souza

President & COO

Lindi Skin

Director, Professional Liaison

Dynamis Therapeutics

Associate Director for Research

Development Associates, Inc.

JD

Founding Partner
Executive Vice President

126 Cathedral Street
Aloysius, Butler & Clark

Bryan

MD

Neurologist

Diamond

Louis

MB, ChB, FACP

Vice President & Medical Director

Lankenau Medical Office
Building
MEDSTAT Group

Docherty

John

MD

President & CEO

Comprehensive Neuroscience

Doshi

Dilesh

PharmD

Associate Director, Regional Outcomes
Research

Ortho-McNeil Janssen Scientific
Affairs, LLC

Druby

Thomas

Vice President of I/T & CIO

Blue Cross of NE PA

Edman

David

Managing Partner

Risk Management Partners, LLC

Eng

Benjamin

Senior Medical Director, Group Leader

Pfizer Global Pharmaceuticals

PhD., MS
PhD

Feldman

Michael

MD, MA
MD, FACC

Feldman

Marc

MBA

Fernley

G.A. Taylor

Fetterolf

Donald

MD, MBA

President, Graduate Education Foundation

Graduate Hospital
American Board of Internal
Medicine

President & CEO
Corporate VP Strategic Initiatives
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Fernley & Fernley, Inc.
Matria Healthcare, Inc.

Last Name

First Name

Degree
MD, FACP

Title

Company

Fleegler

Edward

Flynn

Mickey

Freeman

Robert

Fried

Jeffrey

George

Dawn

MBA

Gerson
Gill

Benjamin
James

MD
MD, MPH

Medical Director
President, Director of Health Services
Research Group

University Services
Delaware Valley Outcomes
Research

Gitman

Paul

MD

Medical Director, VP Quality

Gorton

MD, MHSA

CMO

Grusenmeyer

Christopher
(Kit)
Patrick

Long Island Jewish Medical
Center
APS Healthcare, Inc.

ScD, FACHE

Vice President

Christiana Care Health System

Hadley

Trevor

PhD

Professor of Psychology in Psychiatry

Ctr for Mental Health Policy &
Services Research

Hamill

C. Taney

Chief Executive Officer

Women Business Leaders of the
U.S. Health Care Industry
Foundation

Harris

Daniel

PhD

Senior Project Director

The CNA Corporation

Hayes
Helmer

Winifred
Lynn

PhD
MD, FACP, MBA, FACPE

President and CEO
President

Hayes, Incorporated
DRD Consulting, Inc.

Henochowicz

Stuart

MD, MBA, FACP

Herman

Barry

MD, MMM

PhD

Medical Director

Independence Blue Cross

President

Pennsylvania BIO

Principal

The Freeman Group, LLC

President and CEO

Beebe Medical Center
Wesley Enhanced Living

Internal Medicine and Allergy
Associates
Senior Director, U.S. Regional Medical &
Research Specialist

Pfizer, Inc.

Hess

Gregory

MD, MBA, MSc

VP, New Product Dev. & Commercialization

Surveillance Data Incorporated

Higashi

Mitchell

PhD

Senior Director Health Economics and
Outcomes Research / GE Healthcare

GE Healthcare

Hughes

Tom

PhD

Senior Portfolio Scientist

Eli Lilly & Company
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Last Name

First Name

Degree

Jacobs

Mark

Jacoby

Richard

MD

Jhaveri

Vishu

MD

Joffe

Howard

Esquire

Kain

Dennis

FACHE

Karpay

Title

Company

Director of Technology Services

WellSpan Health

COO & Corp. Med. Director

FutureHealth Corporation
Best Evidence, Inc.

Senior Vice President

Tyler & Company

Kenneth

VP & Group Publisher

Physicans Practice

Katz

Gerald

President

Kurt Salmon Associates

Kehr

Bruce

MD

Chairman and CEO

InforMedix Inc.

Kelly

John

MD, PhD

Chief Health and Medical Officer

Union Pacific Railroad

Keshishian

Dale

Consultant

Gap International, Inc.

Kim

Edward

MD, MBA

Associate Director

Bristol-Myers Squibb Company

Bob

Kocher

MD

Engagement Manager

McKinsey & Company, Inc.

Kountz
Kovner

David
Anthony

MD
PhD

Assoc. Dean for Postgrad Ed.
Professor of Public and Health Managment

Univ. of Medicine & Dentistry of
NJ
NYU/Wagner Graduate School
of Public Service

Lawless

Stephen

MD

Chief Knowledge and Quality Officer

Nemours

Lazarus

Arthur

MD, MBA

Sr. Director of Clinical Research

Leider

Harry

MD , MBA, FACPE

Chief Medical Officer

AstraZeneca Pharamaceuticals
LP
XLHealth

Lerner

Jeffrey

PhD

President & CEO

ECRI

Locklear

Julie

PharmD, MBA

Associate Director, Outcomes Research

AstraZeneca Pharmaceuticals LP

Founder and CEO

Scientific Intake

Senior Vice President, Science Policy

UBC (United BioSource
Corporation)

President and CEO

Main Line Health

Longley

William

Luce

Bryan

Lynch

John (Jack)

Macgregor

Robert

FACHE

Manager, Market & Client Development
Healthcare Consulting

Parente Randolph, PC

Maclean

Ross

MD, MBA

Director, Outcomes Research, Immunology

Bristol-Myers Squibb Company

PhD, MBA
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Last Name

First Name

Markson

Leona

Martin

Degree
ScD

Title

Company

Executive Director, Outcomes Research &
Mgmt.

Merck & Co., Inc.

Paul

Principal

The Paul Martin Company, LLC

May

Jeanette

Director, Research

Disease Management Association
of America (DMAA)

McCloskey

Richard

MD

VP, Medical Technology

Johnson & Johnson
Development Corp.

McGivney

William

Ph.D

CEO

National Comprehensive Cancer
Network

McGuckin

Maryanne

Dr. ScEd., MT

Senior Research Investigator

University of Penn - School of
Medicine

McLaughlinq

Michael

MD

Principal, Chief Scientific Officer

Peloton Advantage

Mehr

Stanton

President

SM Health Communications

Messikomer

Carla

PhD

President

The Acadia Institute

Miller

Stanton

MD, MPH

Medical Director

Lourdes Health System

Mirkin

David

MD

Prinicipal & Healthcare Mgmt. Consultant

Milliman, Inc.

Mochan

Eugene

PhD, DO

Associate Dean for Primary Care

Philadelphia College of
Osteopathic Medicine

Monnier

John

Moore

David

Morey

John

Presidential Management Fellow
President/CEO

CMS Region III
VoxVue Corporation |
Waltham/Boston

Morrow

Kaye

Assistant Division Director

Department of Human Services
State of NJ

Murphy

Karen

CEO

Physicians Health Alliance, Inc.

Nace

David

MD

VP and CMO

Mckesson Health Solutions

Nash

Esther

MD

Sr. Medical Director, Health Management
Programs

Independence Blue Cross
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Last Name

First Name

Degree

Newman

Andrew

MD, JD, LLM

Owens

Gary

MD

Paxman

Dalton

Pelberg

Title

Company

Associate Director, Health Law Studies and
Adjunct Professor of Law

Widener University School of
Law, Health Law Institute

PhD

Regional Health Administrator

Office of Public Health &
Science, US DHHS

Arthur

MD, MPA

President and Chief Medical Officer

Schaller Anderson Inc.

Pendrak

Robert
Steven

Risk Mgmt Dir., Medical Professional
Liability
EVP and Chief Medical Officer

Inservco Insurance Services, Inc.

Peskin

MD, MS, ARM,
DFASHRM
MD, MBA

Peterson

P. Michael

EdD

Associate Professor

University of Delaware

Phillips

Donald

PharmD

CEO

Vox Medica

Phipps

Etienne

PhD

Director, Einstein Ctr. for Urban Hlth. Policy
& Research

Albert Einstein Healthcare
Network

Piper

Letty

RN, MSN

Chief Clinical Operations Officer

Good Shepherd Rehabilitation
Hospital

Pressman

Gregg

MD, FACC

Associate Professor of Medicine

Germantown Community
Health Services

Provencher
Pyenson

Thomas
Bruce

FSA, MAAA

Senior Director
Principal & Consulting Actuary

Pfizer, Inc.
Milliman, Inc.

Qaseem

Amir

MD, PhD, MHA

Senior Medical Associate

American College of Physicians
(ACP)

Sanuj

Ravindran

MD

Principal

Radius Ventures

Resnic

JoAnne

RN, BSN< MBA

VP, Sales

Mid-Atlantic - CarePages

Roehl

Barbara

MD, MBA

Rohner

Thomas

MD

Emeritus Professor of Surgery

Penn State Univ., College of
Medicine

Rosko

Michael

PhD

Professor

Widener University

Rupnow

Marcia

PhD

Director, Outcomes Research

Ortho-McNeil Janssen Scientific
Affairs, LLC
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MediMedia USA

Last Name

First Name

Degree

Sacks

Lester

MD, MPH, PhD

Scherpbier

Harm

MD

Schoenfeld

Shelley

Schrogie
Schwartz
Seeger

Title

Company

Editor

Focus

BS

Hospital Relations Strategist

Physicans Practice

John
Marshall

MD
MD

Consultant, Clinical Research & Development
Pediatric Surgeon

Barbara

PharmD, RPh, MSA

Sr. Corporate Account Manager

Centocor, Inc.

Shafa

Mehrdad

MD, MMM

Chief Medical Officer

Maricopa Managed Care Systems

Shapiro

Eve

Sheils

Paul

Sigmond

Robert

Slocum

Kim

Smith

Robin

Smith
Snow

St. Christopher’s Hospital for
Children

Medical Writer
Silverado HealthPartners, LLC
MA

2 Franklintown Boulevard
President

KDS Consulting, LLC

MD, MBA

CEO

Phase III Medical Inc. / Neostem

Cecilia
Vincenza

DO
MD, FACP

Chair, Department of Medicine
Director, Clinical Programs and Quality of
Care

The Reading Hospital & Medical
Center
American College of Physicians
(ACP)

Sokol

Michael

MD, MS

Medical Director, Health Management
Innovations

Sorin

David

Esquire

Stillman

Paula

MD, MBA

Stombler

Robin

Tang

Boxiong

Tanio

GlaxoSmithKline
Management Mpowerment
Associates

Sr. Vice President Special Projects

Christiana Care Health System

President

Auburn Health Strategies, LLC

Associate Director for Research

Centocor, Inc.

Craig

MD., PhD
MD

Principal

McKinsey & Company, Inc.

Terzian

Raffi

MD, MPH

Medical Director, Occupational & Travel
Health

Main Line Health

Toscani

Michael

PharmD

Totten

Zoe

MSN, CNM

Clinical Solutions, Inc.
Founder

The Full Yield, Inc.
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Last Name

First Name

Degree

Turpin

Robin

Turzanski

Edward

PhD

Umland

Elena

PharmD

Valerian

Christopher

DO., MMM

Van Brussel

Roger

van Steenwyk

John

Veit

Title

Company

Director, Outcomes Research & Management

Merck & Co., Inc.

Counselor to the President

La Salle University

Associate Dean for Academic Affairs

TJU-Jefferson College of Health
Professions

Vice President, Sales

ICW America

AB, MBA

President

Health Economics Inc.

Kenneth

DO., MBA, FACOFP

Senior VP, Academic Affairs & Dean

Philadelphia College of
Osteopathic Medicine

Villare

Robert

MD

Vinson

Carey

MD, MPM

Vogel

Warren

Vogenberg

F. Randy

RPh, PhD

White

Richard

PhD, Mbe

Wiesendanger

John

Woods

W. David

Wright

Delaware Valley Physicians &
Surgeons, P.A.
VP, Quality and Medical Performance
Management
Esquire
Senior Vice President

Highmark
Eckert Seamans Cherin &
Mellott, LLC
Aon Consulting, Inc.

Director Pharmacoeconomics and Outcomes
Research

Endo Pharmaceuticals

Chief Executive Officer

West Virginia Medical Institute,
Inc.

PhD

President

Healthcare Media International,
Inc.

Robert

M.D., FACP

Director

Scranton Temple Residency
Program

Zajac

Thomas

MBA

President

CareScience

Zeddies

Timothy

PhD, MHSA

Senior Director Research & Evaluation

Independence Blue Cross

Zinn

Jacqueline S.

PhD

Program Coordinator

Temple University

Zissman

Joshua

FACHE, CPHQ, MBA

Administrator

Thomas Jefferson University
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